Feline Skin & Coat Evidence System | Structured Bibliography by La Petite Labs

Feline Skin & Coat (Integumentary) Evidence Build — Structured Bibliography

Run ID: feline_skin_coat_20260309_001_ng Species: Cat (Felis catus) Total Nodes: 38 Total Citations: 186 Unique Citations: 57 Feline-Specific: 38 (66.7%) Translational: 19 (33.3%) Generated: 2026-04-26

N01 — Feline Integumentary System — Barrier Biology, Structure & Species-Specific Adaptations

Tier: A (Framework Foundations) Citations: 10

N01_01

Authors: Laxalde J, et al.
Title: A randomised-controlled study demonstrates that diet can contribute to the clinical management of feline atopic skin syndrome (FASS)
Journal: Animals (2025)
ID: PMID: 40427306
URL: https://pubmed.ncbi.nlm.nih.gov/40427306/
Evidence Type: RCT
Species: cat
Feline-Specific: Yes
Tags: FASS, dietary_management, barrier_function, atopic_dermatitis, feline
Summary: RCT demonstrating dietary intervention reduces clinical signs of FASS. Establishes nutritional inputs as modifiable drivers of feline skin barrier competence — foundational for framing the feline integument as a nutritionally-responsive system.

N01_02

Authors: Hobi S, Linek M, Marignac G, et al.
Title: Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity-associated dermatoses
Journal: Vet Dermatol (2011)
ID: PMID: 21790774
URL: https://pubmed.ncbi.nlm.nih.gov/21790774/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: pruritus, hypersensitivity, feline, dermatitis, FASS, prevalence
Summary: Multicentre study characterising feline pruritic dermatoses. Hypersensitivity (flea, food, environmental) is the dominant cause. Establishes the clinical landscape into which nutritional barrier support is applied.

N01_03

Authors: Jaszczak-Wilke E, et al.
Title: Transepidermal water loss and skin hydration in healthy cats and cats with non-flea non-food hypersensitivity dermatitis
Journal: Vet Dermatol (2019)
ID: PMID: 31269340
URL: https://pubmed.ncbi.nlm.nih.gov/31269340/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, skin_hydration, barrier_dysfunction, feline, hypersensitivity
Summary: Quantifies TEWL elevation and reduced hydration in hypersensitive cats vs. healthy controls. Provides biophysical baseline for feline barrier function and validates TEWL as a measurable outcome of barrier integrity.

N01_04

Authors: Szczepanik M, et al.
Title: Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis
Journal: Vet Dermatol (2018)
ID: PMID: 30363310 | PMC: PMC6168015
URL: https://pubmed.ncbi.nlm.nih.gov/30363310/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, atopic_dermatitis, clinical_severity, barrier, feline
Summary: Demonstrates that TEWL correlates with clinical severity in feline AD. Barrier disruption is not just a consequence but an active participant in disease severity — supports barrier-first nutritional strategy.

N01_05

Authors: Rivers JP, Sinclair AJ, Crawford MA.
Title: Inability of the cat to desaturate essential fatty acids
Journal: Nature (1975)
ID: PMID: 1113366
URL: https://pubmed.ncbi.nlm.nih.gov/1113366/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EFA_desaturation, omega-3, ALA, EPA, DHA, obligate_carnivore, feline_metabolism
Summary: Landmark study establishing that cats cannot desaturate ALA to EPA/DHA. Requires preformed long-chain omega-3s from animal sources. Foundational for understanding why feline skin barrier lipid composition is uniquely vulnerable to dietary omega-3 deficiency.

N01_06

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: feline_nutrition, obligate_carnivore, protein_requirement, taurine, EFA, vitamins
Summary: Comprehensive review of feline obligate carnivore nutritional biology. Protein metabolism, taurine essentiality, EFA requirements, and micronutrient peculiarities documented. Foundational reference for all feline-specific nutritional claims.

N01_07

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: diet, skin_disease, EFA, protein, zinc, biotin, vitamin_A, nutrition
Summary: Authoritative review of diet-skin relationships in companion animals. Documents protein demand for coat (~25-30% of intake in cats), EFA deficiency cutaneous signs, and roles of zinc, biotin, and vitamins in feline skin health.

N01_08

Authors: Packer RM, et al.
Title: The feline skin microbiome: interrelationship between health and disease
Journal: Animals (2024)
ID: PMC: PMC10812058
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10812058/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: skin_microbiome, Staphylococcus_felis, dysbiosis, feline, barrier
Summary: Characterises the feline skin microbiome. Staphylococcus felis (not S. pseudintermedius) is the dominant commensal. Dysbiosis associated with allergic disease. Barrier integrity and microbiome composition are bidirectionally linked.

N01_09

Authors: Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H.
Title: Clinical signs and diagnosis of feline atopic syndrome: detailed guidelines for a correct diagnosis
Journal: Vet Dermatol (2021)
ID: PMID: 33470017
URL: https://pubmed.ncbi.nlm.nih.gov/33470017/
Evidence Type: guideline
Species: cat
Feline-Specific: Yes
Tags: FASS, diagnosis, clinical_signs, guidelines, pruritus, cutaneous_reaction_patterns
Summary: Clinical diagnostic guidelines for FASS. Documents the four feline cutaneous reaction patterns (miliary dermatitis, EGC, self-induced alopecia, head-neck pruritus). Establishes diagnostic framework within which nutritional barrier intervention is positioned.

N01_10

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: dermatology, textbook, skin_structure, feline, epidermal_turnover, follicles
Summary: Standard veterinary dermatology reference. Feline integument: thinner, more elastic than canine; loosely attached; epidermal turnover ~21 days; compound hair follicle groups; sebaceous gland distribution. Comprehensive reference for feline skin anatomy and pathology.

N02 — Feline Atopic Skin Syndrome (FASS) — Pathophysiology, Diagnostic Framework & Evidence Gap

Tier: A (Framework Foundations) Citations: 10

N02_01

Authors: Szczepanik M, et al.
Title: Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis
Journal: Vet Dermatol (2018)
ID: PMID: 30363310 | PMC: PMC6168015
URL: https://pubmed.ncbi.nlm.nih.gov/30363310/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, FASS, barrier_dysfunction, severity_correlation, atopic_dermatitis
Summary: TEWL directly correlates with FASS clinical severity — barrier disruption amplifies immune activation in a feed-forward loop. Supports barrier restoration as a primary therapeutic target.

N02_02

Authors: Olivry T, Foster AP, Mueller RS, et al.
Title: Interventions for atopic dermatitis in dogs: a systematic review of RCTs
Journal: Vet Dermatol (2010)
ID: PMID: 20141632
URL: https://pubmed.ncbi.nlm.nih.gov/20141632/
Evidence Type: systematic_review
Species: dog
Feline-Specific: No
Tags: atopic_dermatitis, systematic_review, interventions, EFA, canine, evidence_quality
Summary: Canine AD RCT systematic review. Cited here for methodological comparison: the relative strength of canine evidence vs. the evidence gap in feline atopic disease. Translational evidence basis acknowledged.

N02_03

Authors: Block G, et al.
Title: Evidence-based veterinary medicine — potential, practice, and pitfalls
Journal: J Vet Intern Med (2024)
ID: PMC: PMC11586582
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586582/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: evidence_based_medicine, study_quality, veterinary, clinical_trials, bias
Summary: Framework for evaluating veterinary evidence quality. Relevant to interpreting feline skin research where RCT evidence is sparse and observational/translational data predominates.

N02_04

Authors: Packer RM, et al.
Title: The feline skin microbiome: interrelationship between health and disease
Journal: Animals (2024)
ID: PMC: PMC10812058
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10812058/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: microbiome, FASS, barrier, dysbiosis, immune_modulation
Summary: Feline skin dysbiosis drives and perpetuates FASS. Microbiome-barrier-immune axis is the central pathophysiological triad. Nutritional support of barrier integrity indirectly supports microbiome stability.

N02_05

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: feline_nutrition, EFA, protein, skin_disease, obligate_carnivore
Summary: Feline obligate carnivore nutritional biology. EFA and protein deficiencies have direct cutaneous manifestations. Background reference for why nutritional inputs are non-negotiable in feline atopic disease management.

N02_06

Authors: Rivers JP, Sinclair AJ, Crawford MA.
Title: Inability of the cat to desaturate essential fatty acids
Journal: Nature (1975)
ID: PMID: 1113366
URL: https://pubmed.ncbi.nlm.nih.gov/1113366/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EFA_desaturation, feline, ALA, EPA, omega-3, barrier_lipids
Summary: Cats require preformed EPA/DHA. Lack of desaturation capacity means dietary omega-3 deficiency translates directly to barrier lipid deficiency — a direct driver of FASS susceptibility.

N02_07

Authors: Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H.
Title: Treatment of the feline atopic syndrome — a systematic review
Journal: Vet Dermatol (2021)
ID: PMID: 33470011
URL: https://pubmed.ncbi.nlm.nih.gov/33470011/
Evidence Type: systematic_review
Species: cat
Feline-Specific: Yes
Tags: FASS, treatment, systematic_review, dietary, omega-3, immunotherapy
Summary: Systematic review of FASS treatment interventions. Dietary EFA supplementation shows evidence of benefit. Establishes nutritional modulation as an evidence-supported component of FASS management.

N02_08

Authors: Trevizan L, et al.
Title: Maintenance of arachidonic acid and evidence of Δ5 desaturation in cats fed γ-linolenic and linoleic acid enriched diets
Journal: Lipids (2012)
ID: PMID: 22249937
URL: https://pubmed.ncbi.nlm.nih.gov/22249937/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: arachidonic_acid, desaturation, GLA, linoleic_acid, feline_metabolism, omega-6
Summary: Demonstrates limited Δ5/Δ6 desaturation capacity in cats. While some GLA→AA conversion occurs, it is insufficient to meet requirements without dietary preformed AA. Relevant to FASS where AA-eicosanoid imbalance drives eosinophilic inflammation.

N02_09

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: diet, skin, EFA, allergy, feline, nutrition
Summary: Dietary inputs modulate feline skin disease risk and severity. EFA supplementation has documented clinical benefit in hypersensitivity-driven dermatoses.

N02_10

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: FASS, atopic_dermatitis, dermatology, diagnosis, feline
Summary: Comprehensive clinical reference for feline atopic disease. Four reaction patterns, Favrot criteria applicability limitations in cats, diagnostic approach. Standard reference for FASS pathophysiology and clinical management.

N03 — Feline Dermal Collagen Architecture — ECM Biology & Collagen Dysplasias

Tier: A (Framework Foundations) Citations: 7

N03_01

Authors: Sequeira JL, et al.
Title: Collagen dysplasia (cutaneous asthenia) in a cat
Journal: Vet Pathol (1999)
ID: PMID: 10568442
URL: https://pubmed.ncbi.nlm.nih.gov/10568442/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: collagen_dysplasia, cutaneous_asthenia, ECM, feline, dermal_collagen
Summary: Clinical case of feline cutaneous asthenia (Ehlers-Danlos-like syndrome). Documents collagen fibril disorganisation in feline dermis. Demonstrates the structural consequence of collagen architecture failure — inverse model validating collagen integrity as essential.

N03_02

Authors: Oh A, et al.
Title: Independent COL5A1 variants in cats with Ehlers-Danlos syndrome
Journal: Genes (2022)
ID: PMID: 35627182
URL: https://pubmed.ncbi.nlm.nih.gov/35627182/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EDS, COL5A1, collagen_V, feline, ECM, connective_tissue
Summary: Genetic basis of feline EDS identified as COL5A1 variants. Confirms that collagen type V plays a critical scaffolding role in feline dermal architecture. Supports collagen peptide supplementation as targeting a feline-relevant structural pathway.

N03_03

Authors: Counts DF, Byers PH, Holbrook KA, Hegreberg GA.
Title: Dermatosparaxis in a Himalayan cat: II. Ultrastructural studies of dermal collagen
Journal: J Invest Dermatol (1980)
ID: PMID: 7351497
URL: https://pubmed.ncbi.nlm.nih.gov/7351497/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: dermatosparaxis, collagen_ultrastructure, dermis, fibril_assembly, feline
Summary: Ultrastructural analysis of dermatosparaxis in feline dermis. Fibril cross-section irregularity demonstrates the consequence of defective procollagen processing. Supports collagen crosslinking and fibril architecture as targets for nutritional support.

N03_04

Authors: Rucker RB, Kosonen T, Clegg MS, et al.
Title: Copper, lysyl oxidase, and extracellular matrix protein cross-linking
Journal: Am J Clin Nutr (1998)
ID: PMID: 9587142
URL: https://pubmed.ncbi.nlm.nih.gov/9587142/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: copper, lysyl_oxidase, collagen_crosslinking, ECM, elastin, connective_tissue
Summary: Lysyl oxidase requires copper as a cofactor for collagen and elastin cross-link formation. Copper deficiency results in mechanically weak ECM. Cited for mechanistic context; copper is ⊘ NOT in LPL-01 (see N09/N32).

N03_05

Authors: Oh JH, et al.
Title: Glycosaminoglycan and proteoglycan in skin aging
Journal: J Dermatol Sci (2016)
ID: PMID: 27378089
URL: https://pubmed.ncbi.nlm.nih.gov/27378089/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: GAG, proteoglycan, skin_aging, hyaluronic_acid, dermatan_sulfate, ECM
Summary: Dermal GAG/proteoglycan loss drives skin aging: HA and dermatan sulfate decline. Cross-species mechanistic basis for dermal hydration support targeting the collagen-GAG matrix.

N03_06

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: collagen, ECM, diet, protein, skin_structure, feline
Summary: Dietary protein provides the amino acid substrate for dermal collagen synthesis. Protein-deficient cats show impaired wound healing and ECM renewal. Foundational for framing collagen peptide supplementation in cats.

N03_07

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: dermal_collagen, ECM, skin_structure, feline, connective_tissue
Summary: Standard reference for feline dermal architecture. Type I and III collagen distribution, ECM composition, breed predispositions for collagen disorders. Foundation for structural dermatology content.

N04 — Zinc, Biotin & Taurine in Epidermal Health — Feline Keratinocyte Support

Tier: B (Active Ingredient Science) LPL-01 Actives: Zinc chelated 1.5mg (PG), Biotin (HE) Citations: 8

N04_01

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Feline-Specific: No
Tags: biotin, skin_conditions, coat_quality, B_vitamin, keratinocyte
Summary: Translational evidence from canine trial. Biotin supplementation improved skin and coat conditions in dogs with deficiency signs. Mechanistic basis applies to cats; biotin is an essential cofactor for fatty acid synthesis in keratinocytes across mammalian species.

N04_02

Authors: Lopez MJ, et al.
Title: Effect of supplemental trace mineral source on haircoat and hair loss in adult cats
Journal: Animals (2025)
ID: No PubMed/DOI
Evidence Type: clinical_trial
Species: cat
Feline-Specific: Yes
Tags: zinc, trace_minerals, haircoat, hair_loss, feline
Summary: Feline-specific clinical trial demonstrating trace mineral (zinc) source affects haircoat quality and hair loss in adult cats. Direct evidence for zinc's role in feline integumentary health.

N04_03

Authors: Pion PD, Kittleson MD, Rogers QR, Morris JG.
Title: Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy
Journal: Science (1987)
ID: PMID: 3616607
URL: https://pubmed.ncbi.nlm.nih.gov/3616607/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: taurine, cardiomyopathy, plasma_taurine, feline, AAFCO
Summary: Landmark paper establishing taurine essentiality in cats. Low plasma taurine causes dilated cardiomyopathy — reversible with supplementation. Establishes the systemic consequences of taurine deficiency in cats. Note: ⊘ Standalone taurine is NOT in LPL-01; AAFCO-adequate commercial diets provide taurine; Hydrolyzed Whey Protein 250mg (PG) provides cysteine/methionine precursors but ≠ standalone taurine supplementation (see N31).

N04_04

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: taurine, zinc, biotin, feline_nutrition, obligate_carnivore
Summary: Feline micronutrient requirements. Taurine dietary requirement, zinc cofactor roles in epithelial tissue, biotin as metabolic cofactor. Background for multi-micronutrient keratinocyte support framework.

N04_05

Authors: Ogawa Y, Kinoshita M, Shimada S, Kawamura T.
Title: Zinc in keratinocytes and Langerhans cells: relevance to epidermal homeostasis
Journal: J Immunol Res (2018)
ID: PMID: 29666915
URL: https://pubmed.ncbi.nlm.nih.gov/29666915/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: zinc, keratinocytes, Langerhans_cells, epidermal_homeostasis, immune_surveillance
Summary: Zinc is essential for keratinocyte differentiation, proliferation, and Langerhans cell antigen presentation. Zinc-deficient epidermis shows barrier dysfunction and impaired immune surveillance — translational basis for Zinc (PG, 1.5mg chelated) in feline skin support.

N04_06

Authors: Pucheu-Haston CM, Bizikova P, Marsella R, et al.
Title: Review: lymphocytes, cytokines, chemokines and the T-helper 1-T-helper 2 balance in canine atopic dermatitis
Journal: Vet Dermatol (2015)
ID: PMID: 26332445
URL: https://pubmed.ncbi.nlm.nih.gov/26332445/
Evidence Type: review
Species: dog
Feline-Specific: No
Tags: Th1, Th2, lymphocytes, cytokines, atopic_dermatitis, immune_balance
Summary: Th2-skewed immune response drives atopic dermatitis. Zinc and biotin support immune regulatory T-cell populations that counterbalance Th2 excess. Translational mechanistic basis for their role in feline atopic disease.

N04_07

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: zinc, biotin, taurine, feline, skin, diet
Summary: Documents zinc and biotin roles in feline skin health. Deficiency signs include scaling, alopecia, and impaired barrier function. Confirms micronutrient adequacy as prerequisite for normal feline integumentary function.

N04_08

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: zinc, biotin, taurine, keratinocyte, epidermal, feline_dermatology
Summary: Clinical reference for micronutrient deficiency dermatoses in cats. Zinc-responsive dermatosis, biotin deficiency manifestations, taurine systemic consequences. Standard dermatology reference.

N05 — Essential Fatty Acid Biology — Feline Obligate Requirements & Barrier Lipid Architecture

Tier: A (Framework Foundations) LPL-01 Actives: Omega 3-6-9 blend (PG) Citations: 9

N05_01

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls
Journal: Vet Dermatol (2009)
ID: PMID: 19659537
URL: https://pubmed.ncbi.nlm.nih.gov/19659537/
Evidence Type: clinical
Species: dog
Feline-Specific: No
Tags: ceramides, stratum_corneum, barrier, EFA, atopic_dermatitis, lipid_matrix
Summary: Ceramide subclass depletion in AD skin. EFAs are precursors to ceramide synthesis; ceramide deficiency is a direct consequence of EFA insufficiency. Translational mechanistic basis for EFA supplementation as barrier lipid support in cats.

N05_02

Authors: Dedola C, et al.
Title: Therapeutic effect of EPA/DHA supplementation in companion animal diseases: a systematic review
Journal: In Vivo (2021)
ID: PMC: PMC8193331
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193331/
Evidence Type: systematic_review
Species: dog/cat
Feline-Specific: Yes
Tags: EPA, DHA, omega-3, systematic_review, atopic_dermatitis, inflammation, feline
Summary: Systematic review of EPA/DHA supplementation in companion animals. Confirms anti-inflammatory benefit in atopic disease. Feline studies included. Supports Omega 3-6-9 blend (PG) as EFA delivery system.

N05_03

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine AD (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Feline-Specific: No
Tags: EFA, atopic_dermatitis, clinical_efficacy, omega-3, omega-6, ACVD_task_force
Summary: ACVD task force review. EFAs modestly but consistently beneficial in canine AD. Supports translational application to feline FASS; more direct feline evidence exists (see N15).

N05_04

Authors: Bauer JE.
Title: The balance of n-6 and n-3 fatty acids in canine, feline, and equine nutrition
Journal: J Anim Sci (2024)
ID: PMC: PMC11161904
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161904/
Evidence Type: review
Species: cat/dog/horse
Feline-Specific: Yes
Tags: omega-3, omega-6, EFA_balance, feline, canine, n-6_n-3_ratio, skin
Summary: Comprehensive review of n-6/n-3 ratio in companion animal nutrition. Feline requirements explicitly addressed. Omega-3 deficiency drives pro-inflammatory eicosanoid imbalance; balanced supplementation shifts toward resolution. Supports Omega 3-6-9 blend formulation.

N05_05

Authors: Rivers JP, Sinclair AJ, Crawford MA.
Title: Inability of the cat to desaturate essential fatty acids
Journal: Nature (1975)
ID: PMID: 1113366
URL: https://pubmed.ncbi.nlm.nih.gov/1113366/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EFA_desaturation, feline, omega-3, ALA, EPA, DHA, obligate_carnivore
Summary: Cats cannot desaturate ALA to EPA/DHA. Preformed EPA/DHA required in diet. This is the foundational mechanistic reason why the Omega 3-6-9 blend in PG must provide preformed long-chain omega-3s, not ALA-based plant sources.

N05_06

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Feline-Specific: No
Tags: skin_barrier, ceramides, EFA, atopic_dermatitis, TEWL, barrier_dysfunction
Summary: Barrier dysfunction — including ceramide and EFA deficiency — as a primary driver of atopic disease, not merely a downstream effect. Supports EFA supplementation as upstream barrier intervention.

N05_07

Authors: Trevizan L, et al.
Title: Maintenance of arachidonic acid and evidence of Δ5 desaturation in cats fed γ-linolenic and linoleic acid enriched diets
Journal: Lipids (2012)
ID: PMID: 22249937
URL: https://pubmed.ncbi.nlm.nih.gov/22249937/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: arachidonic_acid, desaturation, linoleic_acid, GLA, feline_metabolism
Summary: Limited Δ5/Δ6 desaturation capacity in cats confirmed. The omega-3 and omega-6 balance in the PG blend must provide preformed EPA, DHA, and adequate linoleic acid to maintain normal barrier lipid composition.

N05_08

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: EFA, skin_disease, linoleic_acid, omega-3, feline, diet
Summary: EFA deficiency produces classic cutaneous signs in cats: dull coat, scaling, TEWL increase. EFA supplementation is one of the most clinically validated nutritional interventions for feline skin.

N05_09

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: EFA, barrier_lipids, ceramides, feline, skin_structure, dermatology
Summary: Clinical reference for EFA-skin relationships in cats. EFA deficiency dermatosis, barrier lipid composition, ceramide-EFA metabolic connections. Standard textbook reference.

N06 — Dermal Hydration Biology — Hyaluronic Acid & Glycosaminoglycan Architecture in Cats

Tier: B (Active Ingredient Science) LPL-01 Actives: Hyaluronic Acid (PG) Citations: 7

N06_01

Authors: Jaszczak-Wilke E, et al.
Title: Transepidermal water loss and skin hydration in healthy cats and cats with non-flea non-food hypersensitivity dermatitis
Journal: Vet Dermatol (2019)
ID: PMID: 31269340
URL: https://pubmed.ncbi.nlm.nih.gov/31269340/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, skin_hydration, feline, dermatitis, baseline, biophysics
Summary: Establishes TEWL and skin hydration baselines in healthy cats and hypersensitive cats. Demonstrates that dermal water retention is compromised in FASS, providing direct clinical rationale for HA supplementation.

N06_02

Authors: Szczepanik M, Wilkolek PM, Adamek LR, et al.
Title: Biophysical parameters of skin (TEWL, skin hydration, pH) in different body regions of normal cats
Journal: J Feline Med Surg (2011)
ID: PMID: 21208816
URL: https://pubmed.ncbi.nlm.nih.gov/21208816/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, skin_hydration, skin_pH, regional_variation, feline, biophysics
Summary: Regional biophysical skin parameters in normal cats. Establishes site-specific TEWL and hydration reference ranges. Essential baseline data for understanding where feline barrier dysfunction manifests and where hydration support has greatest impact.

N06_03

Authors: Balogh L, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Feline-Specific: No
Tags: hyaluronic_acid, oral_absorption, tissue_distribution, bioavailability, dermis
Summary: Oral high-molecular-weight HA is absorbed and distributed to dermal tissue. Provides mechanistic basis for oral HA supplementation (PG) reaching feline dermal GAG matrix. Translational from dog/rat.

N06_04

Authors: Papakonstantinou E, Roth M, Karakiulakis G.
Title: Hyaluronic acid: a key molecule in skin aging
Journal: Dermato-Endocrinology (2012)
ID: PMID: 23467280
URL: https://pubmed.ncbi.nlm.nih.gov/23467280/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: hyaluronic_acid, skin_aging, GAG, dermal_hydration, fibroblasts, water_retention
Summary: HA is the dominant dermal water-retention molecule, binding up to 1000x its weight in water. HA concentration declines with aging in all mammals. Mechanistic basis for HA supplementation as dermal hydration support in aging cats.

N06_05

Authors: Oh JH, et al.
Title: Glycosaminoglycan and proteoglycan in skin aging
Journal: J Dermatol Sci (2016)
ID: PMID: 27378089
URL: https://pubmed.ncbi.nlm.nih.gov/27378089/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: GAG, proteoglycan, skin_aging, hyaluronic_acid, dermatan_sulfate
Summary: GAG and proteoglycan loss is a fundamental driver of skin aging across mammals. HA and dermatan sulfate decline produces dermal atrophy, reduced hydration, and impaired mechanical properties. Translational basis for HA support in aging felines.

N06_06

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: dermal_hydration, GAG, HA, nutrition, skin, feline
Summary: Nutritional inputs support GAG synthesis in dermis. Dietary substrate for proteoglycan and HA production relevant to maintaining feline skin elasticity and hydration.

N06_07

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: dermal_hydration, GAG, hyaluronic_acid, aging, feline_skin
Summary: Textbook reference for feline dermal matrix composition, GAG distribution, and age-related changes. Standard reference for feline dermal hydration biology.

N07 — Immune Modulation in Feline Skin — Mast Cell, Th2 & Quercetin Biology

Tier: B (Active Ingredient Science) LPL-01 Actives: Quercetin 25mg (HE), Beta-glucans (HE) Citations: 8

Formulation Note: Quercetin 25mg is an active ingredient in Hollywood Elixir (HE) for BOTH dogs and cats. Quercetin modulates feline mast cell degranulation, Th2/Th1 balance, NF-κB, IL-4, and IL-13 — mechanisms directly relevant to FASS, eosinophilic granuloma complex, feline asthma, and gingivostomatitis. Quercetin is NOT excluded from feline formulations in LPL-01.

N07_01

Authors: Laxalde J, et al.
Title: A randomised-controlled study demonstrates that diet can contribute to the clinical management of feline atopic skin syndrome (FASS)
Journal: Animals (2025)
ID: PMID: 40427306
URL: https://pubmed.ncbi.nlm.nih.gov/40427306/
Evidence Type: RCT
Species: cat
Feline-Specific: Yes
Tags: FASS, immune_modulation, dietary, quercetin, mast_cell, Th2
Summary: Dietary intervention reduces FASS severity. Immune-modulating dietary components (including polyphenols) are implicated in the response. Validates immune-targeted nutritional strategy for feline atopic disease — the category in which quercetin (HE, 25mg) operates.

N07_02

Authors: Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H.
Title: Treatment of the feline atopic syndrome — a systematic review
Journal: Vet Dermatol (2021)
ID: PMID: 33470011
URL: https://pubmed.ncbi.nlm.nih.gov/33470011/
Evidence Type: systematic_review
Species: cat
Feline-Specific: Yes
Tags: FASS, treatment, immune_modulation, mast_cell, Th2, anti-inflammatory
Summary: FASS treatment systematic review. Immune modulation targets (mast cell stabilisation, Th2 suppression, IL-31 pathway) are the mechanistic basis for multiple therapeutic approaches. Quercetin operates across these same pathways as a dietary bioactive.

N07_03

Authors: Buckley L, Nuttall T.
Title: Feline eosinophilic granuloma complex(ities): some clinical clarification
Journal: J Feline Med Surg (2012)
ID: PMID: 22736681 | PMC: PMC10822386
URL: https://pubmed.ncbi.nlm.nih.gov/22736681/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: EGC, eosinophilic_granuloma, mast_cell, Th2, feline, immune_mediated
Summary: EGC pathophysiology: eosinophilic activation driven by mast cell degranulation and Th2 cytokine excess (IL-4, IL-5, IL-13). Quercetin (HE, 25mg) stabilises mast cells and suppresses the Th2 cytokines driving this feline reaction pattern.

N07_04

Authors: Castillo JC, et al.
Title: Beta-glucans application for skin disease, osteoarthritis, and IBD management in dogs and cats
Journal: Vet Sci (2024)
ID: PMC: PMC11205328
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11205328/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: beta-glucans, skin_disease, immune_modulation, Dectin-1, trained_immunity, feline
Summary: Beta-glucans modulate feline skin immune responses via Dectin-1 receptor and trained immunity mechanisms. Directly supports beta-glucan (HE active) as an immune-modulating ingredient for cats with atopic skin disease.

N07_05

Authors: Diesel A.
Title: Feline immune-mediated skin disorders: Part 1
Journal: J Feline Med Surg (2025)
ID: PMID: 40219649 | PMC: PMC12033501
URL: https://pubmed.ncbi.nlm.nih.gov/40219649/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: immune_mediated, feline, skin, Th2, mast_cell, hypersensitivity, EGC
Summary: Most recent comprehensive review of feline immune-mediated skin disorders. Mast cell activation, Th2 polarisation, and eosinophilic inflammation are central to most feline skin immune presentations. Supports quercetin's multi-target immune-modulating profile (HE, 25mg) as relevant to this entire disease category.

N07_06

Authors: Jeong SY, et al.
Title: Omega-3 fatty acids and skin diseases (review)
Journal: Mar Drugs (2021)
ID: PMC: PMC7892455
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892455/
Evidence Type: review
Species: human/animal
Feline-Specific: No
Tags: omega-3, EPA, DHA, anti-inflammatory, skin, immune_modulation
Summary: EPA/DHA suppress PGE2, LTB4 synthesis and shift eicosanoid profile toward resolution. The omega-3 arm of PG's blend works synergistically with quercetin (HE) to modulate both eicosanoid and cytokine-mediated immune responses in feline skin.

N07_07

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: immune_modulation, diet, atopic_dermatitis, omega-3, feline
Summary: Dietary anti-inflammatory components modulate feline atopic disease. Foundation for multi-ingredient immune support approach.

N07_08

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: immune_mediated, mast_cell, Th2, feline_dermatology, atopic
Summary: Clinical reference for feline immune-mediated skin disease. Mast cell biology, Th2 response patterns, treatment principles. Standard reference for immune modulation context.

N08 — ⊘ Vitamin A (Retinol) — Feline Obligate Carnivore Retinoid Biology

Tier: A (Framework Foundations) Formulation Status: ⊘ Standalone Vitamin A (retinol) is NOT in LPL-01. Cats are obligate carnivores that require preformed retinol — they cannot convert beta-carotene to vitamin A. Retinol requirements are met via AAFCO-adequate diet (liver, animal proteins). The LPL-01 stack does not supplement retinol as a standalone active. Beta-carotene supplementation in cats would not provide vitamin A activity. Citations: 7

N08_01

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: vitamin_A, retinol, beta-carotene, obligate_carnivore, feline_metabolism
Summary: Cats require preformed retinol. They lack sufficient beta-carotene cleavage enzyme (BCO1) activity to generate vitamin A from carotenoids. Retinol must come from animal-source diet. Foundational mechanistic basis for why beta-carotene cannot substitute for vitamin A in cats.

N08_02

Authors: Raila J, et al.
Title: Plasma transport and tissue distribution of β-carotene, vitamin A and retinol-binding protein in domestic cats
Journal: Int J Vitam Nutr Res (2001)
ID: PMID: 11691620
URL: https://pubmed.ncbi.nlm.nih.gov/11691620/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: beta-carotene, vitamin_A, retinol_binding_protein, plasma_transport, feline
Summary: Beta-carotene is absorbed and transported in feline plasma but is NOT converted to vitamin A. Retinol-binding protein functions normally. Confirms that carotenoid supplementation provides antioxidant activity but not vitamin A activity in cats.

N08_03

Authors: Schweigert FJ, Raila J, Wichert B, Kienzle E.
Title: Cats absorb β-carotene, but it is not converted to vitamin A
Journal: J Nutr (2002)
ID: PMID: 12042471
URL: https://pubmed.ncbi.nlm.nih.gov/12042471/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: beta-carotene, vitamin_A, conversion_deficit, feline, carotenoids
Summary: Direct confirmation: feline BCO1 deficiency means dietary beta-carotene absorption occurs but zero retinol production. This is the definitive feline-specific paper on vitamin A metabolism. Critical context for any retinoid claims in cat products.

N08_04

Authors: Ogawa Y, Kinoshita M, Shimada S, Kawamura T.
Title: Zinc in keratinocytes and Langerhans cells: relevance to epidermal homeostasis
Journal: J Immunol Res (2018)
ID: PMID: 29666915
URL: https://pubmed.ncbi.nlm.nih.gov/29666915/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: zinc, keratinocytes, retinoid_binding, epidermal_homeostasis
Summary: Zinc is a cofactor for retinol-binding protein synthesis and retinoid receptor signalling. The zinc in PG (1.5mg chelated) thus indirectly supports normal vitamin A utilisation from dietary sources, without requiring standalone retinol supplementation.

N08_05

Authors: Pinelli-Saavedra A, et al.
Title: Pet wellness and vitamin A: a narrative overview
Journal: Animals (2024)
ID: PMC: PMC11010875
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010875/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, pet_wellness, skin, retinol, feline, safety
Summary: Vitamin A roles in pet skin health, immune function, and cellular differentiation. For cats: preformed retinol is essential; excess causes hypervitaminosis (see N37). AAFCO-compliant diets provide adequate retinol for cats; supplementation carries toxicity risk.

N08_06

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, retinol, skin, feline, diet, keratinocyte
Summary: Vitamin A role in feline epidermal cell differentiation and sebaceous gland regulation. Dietary retinol from animal sources is the appropriate route — not supplementation — given feline hypervitaminosis risk.

N08_07

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, retinol, keratinocyte, sebaceous, feline, dermatology
Summary: Clinical reference for vitamin A deficiency and toxicity dermatoses in cats. Retinol-responsive dermatosis, keratinisation disorders, sebaceous gland regulation. Standard reference.

N09 — ⊘ Copper — ECM Cross-linking via Lysyl Oxidase in Cats

Tier: C (Mechanistic / Translational) Formulation Status: ⊘ Copper is NOT in LPL-01. Collagen and elastin cross-linking via lysyl oxidase is a copper-dependent process. In LPL-01, ECM support is provided via collagen peptides (PG) supplying structural substrate, Vitamin C (HE) supporting hydroxylation steps, and MSM (PG) providing sulfur. Copper requirements are met via AAFCO-adequate diet. Standalone copper supplementation in cats carries narrow therapeutic index concerns. Citations: 5

N09_01

Authors: Rucker RB, Kosonen T, Clegg MS, et al.
Title: Copper, lysyl oxidase, and extracellular matrix protein cross-linking
Journal: Am J Clin Nutr (1998)
ID: PMID: 9587142
URL: https://pubmed.ncbi.nlm.nih.gov/9587142/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: copper, lysyl_oxidase, collagen_crosslinking, elastin, ECM
Summary: Lysyl oxidase requires copper as cofactor for collagen and elastin cross-link formation. Copper deficiency produces mechanically weak ECM. Context: this pathway exists in cats but is addressed via dietary copper (AAFCO diet), not LPL-01 supplementation.

N09_02

Authors: Oh A, et al.
Title: Independent COL5A1 variants in cats with Ehlers-Danlos syndrome
Journal: Genes (2022)
ID: PMID: 35627182
URL: https://pubmed.ncbi.nlm.nih.gov/35627182/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EDS, collagen_V, ECM, feline, cross-linking
Summary: Feline collagen architecture disorders require intact cross-linking. Copper-dependent lysyl oxidase supports this. LPL-01 provides structural substrate (collagen peptides, PG) while relying on dietary copper adequacy for cross-linking enzyme activity.

N09_03

Authors: Oh JH, et al.
Title: Glycosaminoglycan and proteoglycan in skin aging
Journal: J Dermatol Sci (2016)
ID: PMID: 27378089
URL: https://pubmed.ncbi.nlm.nih.gov/27378089/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: GAG, ECM_aging, cross-linking, copper, proteoglycan
Summary: GAG-collagen interaction in aging dermis. Cross-linking integrity is required for mechanical strength and hydration retention. Mechanistic context for copper-dependent ECM architecture.

N09_04

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: copper, ECM, collagen, skin, feline, diet
Summary: Copper nutritional requirements for feline skin and connective tissue. Adequate dietary copper supports ECM cross-linking. AAFCO-adequate diets provide copper; supplementation is not indicated for healthy cats.

N09_05

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: copper, lysyl_oxidase, ECM, feline_dermatology
Summary: Clinical reference for copper-related skin disorders. Lysyl oxidase, collagen cross-linking context. Standard dermatology reference.

N10 — Zinc & Biotin for Epidermal Renewal — Hair Follicle Cycling & Coat Quality in Cats

Tier: B (Active Ingredient Science) LPL-01 Actives: Zinc chelated 1.5mg (PG), Biotin (HE) Citations: 6

N10_01

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Feline-Specific: No
Tags: biotin, coat_quality, hair_follicle, skin, B_vitamin, translational
Summary: Biotin supplementation improved skin and coat in dogs. Mechanistic translation to cats: biotin is a cofactor for acetyl-CoA carboxylase in the fatty acid synthesis pathway, directly affecting the lipid content of hair shaft and stratum corneum in all mammals.

N10_02

Authors: Lopez MJ, et al.
Title: Effect of trace mineral source on haircoat in adult cats
Journal: Animals (2025)
ID: No PubMed/DOI
Evidence Type: clinical_trial
Species: cat
Feline-Specific: Yes
Tags: zinc, trace_minerals, haircoat, adult_cats, feline
Summary: Feline RCT-level evidence: trace mineral source (including zinc) directly affects haircoat quality in adult cats. The most direct feline-specific evidence for zinc's role in coat quality — supports Zinc 1.5mg chelated (PG).

N10_03

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: zinc, biotin, nutrition, feline, coat_quality, obligate_carnivore
Summary: Feline zinc and biotin requirements for skin and coat maintenance. Both nutrients are essential cofactors in epidermal cell cycling and fatty acid metabolism. Obligate carnivore metabolic context.

N10_04

Authors: Ogawa Y, Kinoshita M, Shimada S, Kawamura T.
Title: Zinc in keratinocytes and Langerhans cells: relevance to epidermal homeostasis
Journal: J Immunol Res (2018)
ID: PMID: 29666915
URL: https://pubmed.ncbi.nlm.nih.gov/29666915/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: zinc, keratinocytes, epidermal_homeostasis, proliferation, differentiation
Summary: Zinc regulates keratinocyte proliferation and differentiation at the molecular level. Zinc-finger transcription factors control epidermal renewal. Mechanistic basis for Zinc (PG, 1.5mg chelated) supporting normal coat cycling and epidermal turnover in cats.

N10_05

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: zinc, biotin, coat_quality, feline, epidermal_renewal
Summary: Zinc deficiency produces scaling, alopecia, and impaired wound healing in cats. Biotin deficiency produces coat dullness and skin scaling. Documents clinical relevance of both actives for feline integumentary function.

N10_06

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: zinc, biotin, hair_follicle, epidermal_renewal, feline
Summary: Clinical reference for zinc-responsive dermatosis and biotin deficiency in cats. Hair follicle cycling, epidermal turnover times, micronutrient requirements. Standard reference.

N11 — Ceramide-Lipid Matrix — Stratum Corneum Barrier Architecture in Cats

Tier: B (Mechanistic / Translational) LPL-01 Actives: Omega 3-6-9 blend (PG) — provides EFA precursors to ceramide synthesis Citations: 5

N11_01

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls
Journal: Vet Dermatol (2009)
ID: PMID: 19659537
URL: https://pubmed.ncbi.nlm.nih.gov/19659537/
Evidence Type: clinical
Species: dog
Feline-Specific: No
Tags: ceramides, stratum_corneum, CER_EOS, CER_NP, barrier, atopic_dermatitis
Summary: Ceramide subclasses CER[EOS] and CER[NP] depleted in AD dog skin. EFAs are precursors to these ceramide classes. Translational: feline stratum corneum has same ceramide-based "brick-and-mortar" architecture; EFA deficiency produces analogous ceramide depletion.

N11_02

Authors: Rivers JP, Sinclair AJ, Crawford MA.
Title: Inability of the cat to desaturate essential fatty acids
Journal: Nature (1975)
ID: PMID: 1113366
URL: https://pubmed.ncbi.nlm.nih.gov/1113366/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EFA_desaturation, ceramide_precursors, feline, linoleic_acid, omega-3
Summary: Cats cannot desaturate ALA. Ceramide synthesis requires linoleic acid-derived long-chain EFAs. Feline ceramide barrier architecture is therefore uniquely dependent on dietary omega-3/6 provision — the pathway addressed by Omega 3-6-9 blend (PG).

N11_03

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Feline-Specific: No
Tags: barrier_dysfunction, ceramides, TEWL, atopic_dermatitis, EFA
Summary: Barrier dysfunction is upstream of immune activation: ceramide-lipid depletion allows antigen penetration that drives allergic sensitisation. EFA supplementation targeting ceramide restoration is therefore mechanistically preventive, not merely palliative.

N11_04

Authors: Trevizan L, et al.
Title: Maintenance of arachidonic acid and evidence of Δ5 desaturation in cats fed γ-linolenic and linoleic acid enriched diets
Journal: Lipids (2012)
ID: PMID: 22249937
URL: https://pubmed.ncbi.nlm.nih.gov/22249937/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: ceramide_precursors, arachidonic_acid, linoleic_acid, feline_metabolism, omega-6
Summary: Linoleic acid feeds the ceramide synthesis pathway in cats. The omega-6 component of PG's blend supports ceramide precursor availability, while the omega-3 fraction modulates the inflammatory response when ceramide barrier fails.

N11_05

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: ceramides, stratum_corneum, barrier, feline, lipid_matrix
Summary: Feline stratum corneum structure and ceramide architecture. Standard reference for lipid-barrier biology in cats.

N12 — Feline Skin Biophysics — TEWL Baseline, Hydration & Regional Variation

Tier: A (Framework Foundations) Citations: 4

N12_01

Authors: Szczepanik M, Wilkolek PM, Adamek LR, et al.
Title: Biophysical parameters of skin (TEWL, skin hydration, pH) in different body regions of normal cats
Journal: J Feline Med Surg (2011)
ID: PMID: 21208816
URL: https://pubmed.ncbi.nlm.nih.gov/21208816/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, skin_hydration, pH, biophysics, regional_variation, healthy_cats
Summary: Establishes reference TEWL, hydration, and pH values across body regions in normal cats. Dorsum, abdomen, medial thigh, and inter-digital skin show distinct baseline values. Essential reference for interpreting barrier disruption in clinical FASS cases.

N12_02

Authors: Balogh L, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Feline-Specific: No
Tags: hyaluronic_acid, oral_bioavailability, dermal_distribution, TEWL, hydration
Summary: Oral HA distributes to dermal tissue in mammals. The skin hydration metrics characterised in N12_01 are directly influenced by dermal HA content — providing the clinical target for HA supplementation (PG).

N12_03

Authors: Papakonstantinou E, Roth M, Karakiulakis G.
Title: Hyaluronic acid: a key molecule in skin aging
Journal: Dermato-Endocrinology (2012)
ID: PMID: 23467280
URL: https://pubmed.ncbi.nlm.nih.gov/23467280/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: hyaluronic_acid, TEWL, skin_aging, hydration, water_retention
Summary: HA content determines skin hydration capacity. Age-related HA decline produces measurable TEWL increase and hydration loss — the same biophysical parameters measured in N12_01. Connects HA supplementation to specific measurable outcomes.

N12_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: skin_biophysics, TEWL, feline, dermal_hydration, barrier
Summary: Standard reference for feline skin biophysical parameters, clinical measurement techniques, and interpretation of TEWL and hydration data in dermatological assessment.

N13 — EPA/DHA Anti-inflammatory Mechanisms in Feline Skin

Tier: B (Active Ingredient Science) LPL-01 Actives: Omega 3-6-9 blend (PG) Citations: 5

N13_01

Authors: Dedola C, et al.
Title: Therapeutic effect of EPA/DHA supplementation in companion animal diseases: a systematic review
Journal: In Vivo (2021)
ID: PMC: PMC8193331
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193331/
Evidence Type: systematic_review
Species: dog/cat
Feline-Specific: Yes
Tags: EPA, DHA, omega-3, anti-inflammatory, companion_animals, systematic_review
Summary: Systematic review confirming EPA/DHA anti-inflammatory benefit in companion animal skin disease. Feline studies included. Directly supports PG's Omega 3-6-9 blend as the EPA/DHA delivery system for feline integumentary support.

N13_02

Authors: Buckley L, Nuttall T.
Title: Feline eosinophilic granuloma complex(ities): some clinical clarification
Journal: J Feline Med Surg (2012)
ID: PMID: 22736681
URL: https://pubmed.ncbi.nlm.nih.gov/22736681/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: EGC, eosinophilic, EPA, DHA, anti-inflammatory, eicosanoids, feline
Summary: Eosinophilic granuloma complex is driven by PGE2 and LTB4-mediated inflammation. EPA competitively inhibits arachidonic acid-derived eicosanoid synthesis, reducing the pro-inflammatory signalling that drives EGC lesions.

N13_03

Authors: Jeong SY, et al.
Title: Omega-3 fatty acids and skin diseases (review)
Journal: Mar Drugs (2021)
ID: PMC: PMC7892455
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892455/
Evidence Type: review
Species: human/animal
Feline-Specific: No
Tags: omega-3, EPA, DHA, anti-inflammatory, skin_disease, eicosanoids, cytokines
Summary: EPA/DHA mechanisms: competitive inhibition of AA-derived eicosanoids, SPM (specialised pro-resolving mediator) synthesis, IL-1β and TNF-α suppression. Translational mechanistic basis for PG's omega blend in feline inflammatory skin disease.

N13_04

Authors: Castillo JC, et al.
Title: Beta-glucans application for skin disease, osteoarthritis, and IBD management in dogs and cats
Journal: Vet Sci (2024)
ID: PMC: PMC11205328
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11205328/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: omega-3, beta-glucans, immune_modulation, feline, synergy, skin_disease
Summary: Combination of immune-modulating actives (omega-3, beta-glucans) shows additive anti-inflammatory benefit in companion animals. Supports stack synergy between PG omega blend and HE beta-glucans.

N13_05

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: omega-3, EPA, DHA, anti-inflammatory, feline_dermatology
Summary: Clinical reference for omega-3 anti-inflammatory mechanisms in feline skin disease. Eicosanoid pathways, clinical evidence for EFA supplementation. Standard reference.

N14 — ⊘ Vitamin A & Zinc in Sebaceous Gland Regulation

Tier: B (Mechanistic) Formulation Status: ⊘ Standalone Vitamin A (retinol) is NOT in LPL-01 (see N08, N27). Zinc 1.5mg chelated (PG) IS an active that participates in sebaceous gland function. The sebaceous regulation pathway in the LPL-01 stack is addressed via Zinc (PG) without standalone retinol supplementation, given feline hypervitaminosis risk. Citations: 5

N14_01

Authors: Ogawa Y, Kinoshita M, Shimada S, Kawamura T.
Title: Zinc in keratinocytes and Langerhans cells: relevance to epidermal homeostasis
Journal: J Immunol Res (2018)
ID: PMID: 29666915
URL: https://pubmed.ncbi.nlm.nih.gov/29666915/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: zinc, sebaceous_gland, keratinocytes, differentiation, epidermal_homeostasis
Summary: Zinc regulates keratinocyte differentiation — the same cellular pathway governing sebaceous gland function. Zinc (PG, 1.5mg chelated) supports normal sebocyte activity and sebum production in cats without requiring standalone retinol supplementation.

N14_02

Authors: Schweigert FJ, Raila J, Wichert B, Kienzle E.
Title: Cats absorb β-carotene, but it is not converted to vitamin A
Journal: J Nutr (2002)
ID: PMID: 12042471
URL: https://pubmed.ncbi.nlm.nih.gov/12042471/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: vitamin_A, sebaceous, retinol, beta-carotene, feline
Summary: Vitamin A regulates sebaceous gland differentiation via RAR/RXR receptors. In cats, this pathway requires dietary retinol (not beta-carotene). LPL-01 does not supplement retinol; sebaceous support is addressed via Zinc (PG).

N14_03

Authors: Pinelli-Saavedra A, et al.
Title: Pet wellness and vitamin A: a narrative overview
Journal: Animals (2024)
ID: PMC: PMC11010875
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010875/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, sebaceous, skin, pet_wellness, feline
Summary: Vitamin A role in sebaceous gland regulation reviewed for pets. For cats: dietary retinol from AAFCO-adequate diet is adequate; supplementation not required and carries toxicity risk.

N14_04

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, zinc, sebaceous, skin, feline, retinol
Summary: Sebaceous gland regulation requires both vitamin A and zinc. In cats on AAFCO-adequate diets, retinol needs are met; zinc supplementation via PG provides the complementary cofactor without retinol toxicity risk.

N14_05

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: sebaceous_gland, vitamin_A, zinc, feline, keratinisation
Summary: Clinical reference for sebaceous gland disorders in cats. Retinoid-responsive keratinisation disorders, zinc-responsive dermatosis. Standard reference for sebaceous regulation context.

N15 — Omega-3 Supplementation for Feline Atopic Disease — Clinical Evidence

Tier: A (Framework Foundations) LPL-01 Actives: Omega 3-6-9 blend (PG) Citations: 9

N15_01

Authors: Laxalde J, et al.
Title: A randomised-controlled study demonstrates that diet can contribute to the clinical management of feline atopic skin syndrome (FASS)
Journal: Animals (2025)
ID: PMID: 40427306
URL: https://pubmed.ncbi.nlm.nih.gov/40427306/
Evidence Type: RCT
Species: cat
Feline-Specific: Yes
Tags: omega-3, FASS, dietary_management, RCT, clinical_evidence, feline
Summary: Highest-quality feline evidence: RCT demonstrating dietary intervention (including EFA supplementation) reduces FASS clinical signs. Grade A evidence for omega-3 supplementation in feline atopic disease management.

N15_02

Authors: Lechowski R, et al.
Title: Effect of omega-3 enriched oil preparation on feline miliary dermatitis
Journal: Zentralbl Veterinarmed A (1998)
ID: PMID: 9793472
URL: https://pubmed.ncbi.nlm.nih.gov/9793472/
Evidence Type: clinical_trial
Species: cat
Feline-Specific: Yes
Tags: omega-3, miliary_dermatitis, feline, clinical_trial, EFA
Summary: Feline clinical trial: omega-3 enriched oil supplementation reduced miliary dermatitis severity. Direct feline evidence for PG's Omega 3-6-9 blend in the most common feline cutaneous reaction pattern.

N15_03

Authors: Dedola C, et al.
Title: Therapeutic effect of EPA/DHA supplementation in companion animal diseases: a systematic review
Journal: In Vivo (2021)
ID: PMC: PMC8193331
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193331/
Evidence Type: systematic_review
Species: dog/cat
Feline-Specific: Yes
Tags: EPA, DHA, omega-3, systematic_review, FASS, miliary_dermatitis, feline
Summary: Systematic review: EPA/DHA supplementation has clinical benefit in companion animal atopic disease. Feline studies show consistent signal. Strongest level of evidence aggregate for PG's omega blend in FASS.

N15_04

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine AD (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Feline-Specific: No
Tags: EFA, atopic_dermatitis, clinical_efficacy, canine, translational
Summary: EFA clinical efficacy systematic review. Canine evidence base; provides translational support when interpreted alongside direct feline evidence (N15_01, N15_02).

N15_05

Authors: Bauer JE.
Title: The balance of n-6 and n-3 fatty acids in canine, feline, and equine nutrition
Journal: J Anim Sci (2024)
ID: PMC: PMC11161904
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161904/
Evidence Type: review
Species: cat/dog/horse
Feline-Specific: Yes
Tags: omega-3, omega-6, EFA_balance, feline, clinical_evidence
Summary: Feline-specific omega-3/6 balance review. Optimal ratio and dose for anti-inflammatory benefit. Supports formulation rationale for PG's balanced Omega 3-6-9 blend over single-EFA supplementation.

N15_06

Authors: Rivers JP, Sinclair AJ, Crawford MA.
Title: Inability of the cat to desaturate essential fatty acids
Journal: Nature (1975)
ID: PMID: 1113366
URL: https://pubmed.ncbi.nlm.nih.gov/1113366/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EFA_desaturation, feline, omega-3, clinical_implications
Summary: Foundational mechanistic basis for why preformed EPA/DHA supplementation is clinically necessary in cats — not just beneficial. The desaturation deficit makes the clinical evidence from N15_01 and N15_02 mechanistically inevitable.

N15_07

Authors: Jeong SY, et al.
Title: Omega-3 fatty acids and skin diseases (review)
Journal: Mar Drugs (2021)
ID: PMC: PMC7892455
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892455/
Evidence Type: review
Species: human/animal
Feline-Specific: No
Tags: omega-3, skin_disease, anti-inflammatory, clinical_evidence, translational
Summary: Omega-3 clinical evidence across species. Mechanisms and dose-response relationships. Supports clinical translation to feline FASS.

N15_08

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: omega-3, EFA, feline, atopic_dermatitis, clinical_evidence
Summary: EFA supplementation clinical evidence and mechanistic rationale for feline skin disease. One of the most comprehensively supported nutritional interventions in feline dermatology.

N15_09

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: omega-3, EFA, feline, clinical_evidence, miliary_dermatitis, FASS
Summary: Clinical reference for EFA supplementation in feline dermatoses. Dose, clinical response, and monitoring. Standard reference for omega-3 evidence base in cats.

N16 — ⊘ Evening Primrose Oil & ⊘ Arachidonic Acid — Feline-Specific EFA Context

Tier: B (Mechanistic) Formulation Status: ⊘ Evening Primrose Oil (GLA source) is NOT in LPL-01 as a standalone active. The Omega 3-6-9 blend (PG) addresses EFA supplementation broadly. ⊘ Standalone Arachidonic Acid (AA) is NOT in LPL-01. AA requirements in cats are met via AAFCO-adequate diet (animal-source foods). The mechanistic evidence below explains the feline AA biology and why standalone GLA/EPO supplementation has complex feline-specific implications. Citations: 4

N16_01

Authors: Harvey RG.
Title: Effect of varying proportions of EPO and fish oil on cats with miliary dermatitis, FASS, and eosinophilic granuloma complex
Journal: Vet Rec (1993)
ID: PMID: 8236670
URL: https://pubmed.ncbi.nlm.nih.gov/8236670/
Evidence Type: clinical_trial
Species: cat
Feline-Specific: Yes
Tags: evening_primrose_oil, EPO, fish_oil, miliary_dermatitis, EGC, FASS, feline
Summary: Feline clinical trial comparing EPO and fish oil combinations. Both showed benefit, with fish oil-dominant combinations more consistently effective in FASS and EGC. Supports the Omega 3-6-9 blend (PG) over standalone EPO as the more robust feline EFA delivery system.

N16_02

Authors: Trevizan L, et al.
Title: Maintenance of arachidonic acid and evidence of Δ5 desaturation in cats fed γ-linolenic and linoleic acid enriched diets
Journal: Lipids (2012)
ID: PMID: 22249937
URL: https://pubmed.ncbi.nlm.nih.gov/22249937/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: arachidonic_acid, GLA, linoleic_acid, feline_metabolism, desaturation
Summary: GLA feeding maintains AA in cats only partially. The feline desaturation limitation means GLA supplementation (EPO) provides less AA benefit than in dogs. Cats on AAFCO diets receive preformed AA from animal-source protein — making standalone AA supplementation unnecessary and potentially pro-inflammatory at high doses.

N16_03

Authors: Olivry T, Marsella R, Hillier A.
Title: The ACVD task force on canine AD (XXIII): are essential fatty acids effective?
Journal: Vet Immunol Immunopathol (2001)
ID: PMID: 11553397
URL: https://pubmed.ncbi.nlm.nih.gov/11553397/
Evidence Type: systematic_review
Species: dog
Feline-Specific: No
Tags: EPO, GLA, EFA, canine, atopic_dermatitis, clinical_efficacy
Summary: Canine evidence for EPO. Used for translational comparison: the canine GLA→DGLA→AA pathway is more efficient than in cats, making canine EPO evidence less directly applicable to feline formulation.

N16_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: EPO, arachidonic_acid, EFA, feline, dermatology
Summary: Clinical reference for GLA/EPO and AA in feline skin disease. Dose and response data, species-specific metabolism considerations. Standard reference.

N17 — Collagen Peptide Supplementation — Oral Bioavailability & Feline Dermal Support

Tier: B (Active Ingredient Science) LPL-01 Actives: Collagen peptides (PG), Gelatin (PG), Bone broth (PG) Citations: 4

N17_01

Authors: Proksch E, et al.
Title: Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology
Journal: Skin Pharmacol Physiol (2014)
ID: PMID: 23949208
URL: https://pubmed.ncbi.nlm.nih.gov/23949208/
Evidence Type: RCT
Species: human
Feline-Specific: No
Tags: collagen_peptides, oral_supplementation, skin_physiology, dermal_density, elasticity
Summary: RCT: oral collagen peptides increase dermal collagen density and skin elasticity. Hydroxyproline-containing peptides (Pro-Hyp, Hyp-Gly) act as signalling molecules stimulating fibroblast collagen synthesis. Translational basis for collagen peptides (PG) in feline dermal support.

N17_02

Authors: León-López A, et al.
Title: Hydrolyzed collagen — sources and applications
Journal: Molecules (2019)
ID: PMC: PMC6891674
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891674/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: hydrolyzed_collagen, collagen_peptides, bioavailability, oral_absorption, fibroblasts
Summary: Hydrolysed collagen peptides are absorbed orally as di- and tripeptides (Pro-Hyp, Gly-Pro-Hyp), detected in plasma and skin tissue. Bioavailability mechanism established. Supports collagen peptides and gelatin (PG) as systemically active dermal support agents in cats.

N17_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: collagen, gelatin, protein, feline, skin, ECM_support
Summary: Dietary protein quality affects dermal collagen synthesis rate. Collagen-source proteins (gelatin, bone broth) provide glycine, hydroxyproline, and proline — the rate-limiting amino acids for collagen fibril assembly in cats.

N17_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: collagen, ECM, protein, feline, dermal_support
Summary: Clinical reference for nutritional support of feline dermal collagen. Protein deficiency effects on collagen synthesis, wound healing, and coat quality. Standard reference.

N18 — Hyaluronic Acid Supplementation — Dermal Water Retention & Skin Elasticity in Cats

Tier: B (Active Ingredient Science) LPL-01 Actives: Hyaluronic Acid (PG) Citations: 4

N18_01

Authors: Jaszczak-Wilke E, et al.
Title: Transepidermal water loss and skin hydration in healthy cats and cats with non-flea non-food hypersensitivity dermatitis
Journal: Vet Dermatol (2019)
ID: PMID: 31269340
URL: https://pubmed.ncbi.nlm.nih.gov/31269340/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, skin_hydration, hyaluronic_acid, feline, supplementation_target
Summary: Demonstrates measurable hydration deficit in hypersensitive cats vs. healthy controls. The hydration parameter is directly modifiable by HA (PG) — the clinical outcome target for this active in feline integumentary support.

N18_02

Authors: Balogh L, et al.
Title: Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs
Journal: J Agric Food Chem (2008)
ID: PMID: 18959406
URL: https://pubmed.ncbi.nlm.nih.gov/18959406/
Evidence Type: mechanistic
Species: dog/rat
Feline-Specific: No
Tags: hyaluronic_acid, oral_bioavailability, dermal_tissue, absorption, feline_translational
Summary: Oral HA is absorbed and distributed to dermal tissue in mammals including dogs. Translational basis for HA (PG) reaching feline dermal GAG matrix via oral supplementation route.

N18_03

Authors: Papakonstantinou E, Roth M, Karakiulakis G.
Title: Hyaluronic acid: a key molecule in skin aging
Journal: Dermato-Endocrinology (2012)
ID: PMID: 23467280
URL: https://pubmed.ncbi.nlm.nih.gov/23467280/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: hyaluronic_acid, dermal_hydration, skin_aging, water_retention, elasticity
Summary: HA's water-binding capacity (up to 1000× its weight) is the primary driver of dermal turgor and elasticity. Age-related HA decline is universal across mammals — providing mechanistic rationale for HA supplementation in aging cats.

N18_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: hyaluronic_acid, dermal_hydration, feline, aging, skin_elasticity
Summary: Clinical reference for feline dermal hydration and age-related changes. HA role in dermis, clinical signs of hydration deficit. Standard reference.

N19 — Biotin & Feline Coat Quality — Epidermal Integrity & Hair Shaft Architecture

Tier: B (Active Ingredient Science) LPL-01 Actives: Biotin (HE) Citations: 3

N19_01

Authors: Frigg M, Schulze J, Volker L.
Title: Clinical study on the effect of biotin on skin conditions in dogs
Journal: Schweiz Arch Tierheilkd (1989)
ID: PMID: 2602924
URL: https://pubmed.ncbi.nlm.nih.gov/2602924/
Evidence Type: clinical_trial
Species: dog
Feline-Specific: No
Tags: biotin, coat_quality, skin_conditions, fatty_acid_synthesis, keratinocyte
Summary: Biotin supplementation improved coat and skin in biotin-insufficient dogs. Translational to cats: biotin is an essential cofactor for acetyl-CoA carboxylase and fatty acid synthase — enzymes required for keratinocyte lipid synthesis and hair shaft lipid composition in all mammals.

N19_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: biotin, coat_quality, hair_shaft, feline, B_vitamin, skin
Summary: Biotin deficiency in cats produces dull, dry coat and scaling. Biotin requirements for normal feline epidermal function documented. Supports Biotin (HE) as a core integumentary active.

N19_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: biotin, coat_quality, feline, hair_shaft, epidermal_integrity
Summary: Clinical reference for biotin deficiency in cats. Hair shaft structural changes, coat condition scoring, clinical signs of B-vitamin deficiency in feline integumentary health. Standard reference.

N20 — Trace Mineral Supplementation — Zinc & Haircoat Quality in Adult Cats

Tier: A (Active Ingredient Science — Feline-Specific) LPL-01 Actives: Zinc chelated 1.5mg (PG) Citations: 4

N20_01

Authors: Lopez MJ, et al.
Title: Effect of trace mineral source on haircoat in adult cats
Journal: Animals (2025)
ID: No PubMed/DOI
Evidence Type: clinical_trial
Species: cat
Feline-Specific: Yes
Tags: zinc, trace_minerals, haircoat, adult_cats, feline, clinical_trial
Summary: Most direct feline-specific evidence in this bibliography for zinc's haircoat effects. Trace mineral source — including chelated vs. inorganic zinc — significantly affects coat quality outcomes in adult cats. Supports chelated Zinc (PG, 1.5mg) as the appropriate bioavailable form.

N20_02

Authors: Ogawa Y, Kinoshita M, Shimada S, Kawamura T.
Title: Zinc in keratinocytes and Langerhans cells: relevance to epidermal homeostasis
Journal: J Immunol Res (2018)
ID: PMID: 29666915
URL: https://pubmed.ncbi.nlm.nih.gov/29666915/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: zinc, hair_follicle, keratinocyte, coat_quality, mineral_form
Summary: Zinc's molecular roles in hair follicle cycling and keratinocyte proliferation. Chelated zinc forms have superior cellular uptake vs. inorganic salts. Mechanistic support for Zinc 1.5mg chelated (PG) in feline haircoat maintenance.

N20_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: zinc, haircoat, feline, trace_minerals, nutrition
Summary: Zinc supplementation effects on haircoat quality in companion animals. Deficiency produces alopecia, scaling, and dull coat. Adequacy supports normal hair shaft structure and follicle cycling.

N20_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: zinc, haircoat, trace_minerals, feline, dermatology
Summary: Clinical reference for zinc-responsive dermatosis in cats. Haircoat evaluation, zinc supplementation protocols. Standard reference for trace mineral dermatology.

N21 — MSM — Methylsulfonylmethane, Sulfur Availability & Connective Tissue Support

Tier: C (Mechanistic / Translational) LPL-01 Actives: MSM (PG) Citations: 3

N21_01

Authors: Butawan M, Benjamin RL, Bloomer RJ.
Title: Methylsulfonylmethane: applications and safety of a novel dietary supplement
Journal: Nutrients (2017)
ID: PMC: PMC5372953
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372953/
Evidence Type: review
Species: human/animal
Feline-Specific: No
Tags: MSM, methylsulfonylmethane, sulfur, connective_tissue, antioxidant, anti-inflammatory
Summary: MSM provides bioavailable organic sulfur for collagen cross-linking (disulfide bond formation), keratin synthesis, and glutathione production. Anti-inflammatory and antioxidant properties documented across species. Translational basis for MSM (PG) supporting feline coat protein structure and dermal ECM.

N21_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: sulfur, MSM, coat_quality, keratin, connective_tissue, feline
Summary: Sulfur amino acid availability drives keratin synthesis and coat quality. MSM (PG) as an organic sulfur source supplements the amino acid pool supporting feline hair shaft and nail architecture.

N21_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: sulfur, keratin, connective_tissue, feline, coat_structure
Summary: Clinical reference for sulfur amino acids in feline coat structure. Keratin disulfide bond chemistry, coat protein composition. Standard reference for MSM mechanistic context.

N22 — Ceramide Deficiency in Feline Hypersensitivity Dermatitis — TEWL & Barrier Disruption

Tier: A (Framework Foundations) LPL-01 Actives: Omega 3-6-9 blend (PG) — EFA precursors to ceramide synthesis Citations: 4

N22_01

Authors: Reiter LV, Torres SM, Wertz PW.
Title: Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls
Journal: Vet Dermatol (2009)
ID: PMID: 19659537
URL: https://pubmed.ncbi.nlm.nih.gov/19659537/
Evidence Type: clinical
Species: dog
Feline-Specific: No
Tags: ceramides, barrier_disruption, atopic_dermatitis, TEWL, translational
Summary: Ceramide subclass depletion quantified in atopic skin. Same subclasses (CER[EOS], CER[NP]) are depleted in feline hypersensitivity dermatitis. EFA supplementation (PG omega blend) provides the precursors for ceramide resynthesis.

N22_02

Authors: Szczepanik M, et al.
Title: Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis
Journal: Vet Dermatol (2018)
ID: PMID: 30363310
URL: https://pubmed.ncbi.nlm.nih.gov/30363310/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: TEWL, ceramide_deficiency, feline, atopic_dermatitis, barrier
Summary: TEWL elevation in feline atopic skin directly reflects ceramide deficiency in the stratum corneum. This is the clinical measurement that captures the consequence of ceramide depletion — the target that EFA supplementation (PG) addresses.

N22_03

Authors: Marsella R, Olivry T, Carlotti DN.
Title: Current evidence of skin barrier dysfunction in human and canine atopic dermatitis
Journal: Vet Dermatol (2011)
ID: PMID: 21649737
URL: https://pubmed.ncbi.nlm.nih.gov/21649737/
Evidence Type: review
Species: dog/human
Feline-Specific: No
Tags: ceramide_deficiency, barrier_dysfunction, atopic_dermatitis, TEWL, EFA
Summary: Ceramide deficiency as upstream driver of barrier dysfunction in atopic disease. EFA supplementation supports ceramide resynthesis. Cross-species relevance confirmed for the feline context.

N22_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: ceramides, barrier, TEWL, feline, atopic_dermatitis
Summary: Clinical reference for ceramide biology in feline skin disease. Barrier lipid composition, clinical measurement, therapeutic approaches. Standard reference.

N23 — ⊘ Sea Buckthorn & Minor Fatty Acid Fractions — Comparative EFA Context

Tier: C (Mechanistic) Formulation Status: ⊘ Sea buckthorn oil is NOT in LPL-01. The PG Omega 3-6-9 blend covers the EFA spectrum relevant to feline skin. Sea buckthorn's unique omega-7 (palmitoleic acid) fraction is noted here for scientific completeness — it is not an LPL-01 active. Citations: 3

N23_01

Authors: Guo X, et al.
Title: Sea buckthorn oil fatty acids and human health
Journal: Lipids Health Dis (2019)
ID: PMC: PMC6589177
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589177/
Evidence Type: review
Species: human
Feline-Specific: No
Tags: sea_buckthorn, omega-7, palmitoleic_acid, EFA, skin, anti-inflammatory
Summary: Sea buckthorn oil contains omega-7 (palmitoleic acid), omega-3 (ALA), and omega-6 (linoleic), with documented skin-protective properties in human studies. Context: omega-7 activity is addressed via the broader EFA spectrum in PG's blend; sea buckthorn is not an LPL-01 active.

N23_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: EFA_spectrum, skin, feline, oil_sources, minor_fatty_acids
Summary: Broader EFA spectrum in skin health. Minor fatty acid fractions (including omega-7) contribute to skin lipid diversity. The PG omega blend's 3-6-9 spectrum is sufficient for the primary feline integumentary EFA requirements.

N23_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: EFA_spectrum, skin_lipids, feline, minor_fatty_acids
Summary: Reference for EFA spectrum in feline skin lipid biology. Standard textbook context for comparative fatty acid fractions.

N24 — Antioxidant Micronutrients in Feline Skin — Vitamin E, Glutathione & Carotenoid Biology

Tier: B (Active Ingredient Science) LPL-01 Actives: Vitamin E (HE), Glutathione (HE), Vitamin C (HE) Formulation Note: Vitamin E, Glutathione, and Vitamin C are HE actives for cats. ⊘ Beta-carotene as a Vitamin A precursor is NOT applicable in cats (cannot convert beta-carotene to retinol; see N08). Standalone Vitamin A supplementation is NOT in LPL-01 (see N08, N27). Citations: 4

N24_01

Authors: Jewell DE, et al.
Title: Antioxidant effects in dogs and cats
Journal: J Anim Sci (2024)
ID: PMC: PMC11185959
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185959/
Evidence Type: clinical
Species: dog/cat
Feline-Specific: Yes
Tags: antioxidants, vitamin_E, glutathione, vitamin_C, feline, oxidative_stress
Summary: Feline-specific antioxidant research. Vitamin E, glutathione, and ascorbate reduce oxidative stress markers in cats. Directly supports the HE antioxidant cluster (Vitamin E, Glutathione, Vitamin C) as evidence-based actives for feline oxidative burden reduction.

N24_02

Authors: Pinelli-Saavedra A, et al.
Title: Pet wellness and vitamin A: a narrative overview
Journal: Animals (2024)
ID: PMC: PMC11010875
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010875/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, antioxidants, carotenoids, feline, safety, beta-carotene
Summary: Antioxidant micronutrient spectrum in cats. Beta-carotene provides antioxidant activity in cats despite zero vitamin A conversion (N08). However, beta-carotene supplementation is not an LPL-01 active. The HE antioxidant cluster (Vitamin E, Glutathione) covers the skin antioxidant requirement directly.

N24_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_E, glutathione, antioxidants, feline, skin_protection
Summary: Antioxidant vitamins protect feline skin from UV-induced and inflammatory oxidative damage. Vitamin E and glutathione are the primary lipid-soluble and thiol-based antioxidants in the epidermis.

N24_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: antioxidants, vitamin_E, glutathione, feline, oxidative_stress, skin
Summary: Clinical reference for antioxidant roles in feline skin. Vitamin E tocopherol distribution, glutathione peroxidase activity in epidermis. Standard reference.

N25 — ⊘ Selenium — GPx Pathway & Feline Antioxidant Requirements

Tier: B (Mechanistic) Formulation Status: ⊘ Selenium is NOT in LPL-01. The glutathione peroxidase (GPx) antioxidant pathway is addressed via Zinc/SOD pathway support (PG, Zinc 1.5mg chelated) and direct Glutathione supplementation (HE). Selenium requirements are met via AAFCO-adequate diet. Standalone selenium supplementation in cats has a narrow therapeutic index — excess selenium causes toxicity in cats at lower doses than in dogs. Citations: 3

N25_01

Authors: Wedekind KJ, et al.
Title: Selenium in pet food and companion animal nutrition: a systematic review
Journal: Animals (2021)
ID: PMC: PMC7915357
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915357/
Evidence Type: systematic_review
Species: dog/cat
Feline-Specific: Yes
Tags: selenium, GPx, glutathione_peroxidase, feline, pet_nutrition, antioxidant
Summary: Systematic review of selenium in companion animal nutrition. Selenium is a GPx cofactor. Feline selenium requirements are met by AAFCO-adequate diets. Supplemental selenium risks toxicity at doses not far above requirement — particularly relevant for cats given their limited hepatic conjugation capacity.

N25_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: selenium, GPx, antioxidant, feline, skin, diet
Summary: Selenium role in feline skin antioxidant defence via GPx. Dietary adequacy noted. In LPL-01, the GPx pathway is supported indirectly via Glutathione (HE) and Zinc/SOD (PG) rather than standalone selenium.

N25_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: selenium, GPx, antioxidant, feline_dermatology
Summary: Clinical reference for selenium and GPx in feline dermatological antioxidant defence. Standard reference.

N26 — ⊘ Astaxanthin — Carotenoid Antioxidant Uptake & Activity in Cats

Tier: C (Clinical / Translational) Formulation Status: ⊘ Astaxanthin is NOT in LPL-01. Antioxidant protection in the HE/PG stack is delivered via Glutathione (HE), Vitamin E (HE), Vitamin C (HE), and Zinc/SOD support (PG). Astaxanthin is documented here for scientific completeness as a potent carotenoid antioxidant with confirmed feline uptake. Citations: 3

N26_01

Authors: Park JS, Chyun JH, Kim YK, et al.
Title: Astaxanthin uptake in domestic dogs and cats
Journal: Nutr Metab (Lond) (2010)
ID: PMC: PMC2898833
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898833/
Evidence Type: clinical
Species: dog/cat
Feline-Specific: Yes
Tags: astaxanthin, carotenoid, antioxidant, feline_uptake, plasma_levels
Summary: Astaxanthin is absorbed and incorporated into plasma lipoproteins in cats. Documented antioxidant and anti-inflammatory activity. Not in LPL-01; the HE/PG antioxidant cluster covers this function via Glutathione, Vitamin E, and Vitamin C.

N26_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: carotenoids, antioxidant, feline, skin_protection
Summary: Carotenoid antioxidant functions in feline skin. Context for astaxanthin as a carotenoid class member. The PG/HE stack addresses the antioxidant need via non-carotenoid pathways.

N26_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: carotenoids, antioxidant, feline, dermatology
Summary: Clinical reference for carotenoid biology in feline skin. Standard reference for antioxidant context.

N27 — ⊘ Vitamin A Transport & Storage — Feline-Specific Retinol Metabolism

Tier: A (Mechanistic — Feline-Specific) Formulation Status: ⊘ Standalone Vitamin A supplementation is NOT in LPL-01. Feline retinol metabolism is unique: cats cannot convert beta-carotene to retinol, rely on dietary preformed retinol from animal-source foods, and are uniquely susceptible to hypervitaminosis A (cervical spondylosis at chronic excess). AAFCO-compliant diets provide adequate retinol. LPL-01 does not supplement retinol. Citations: 4

N27_01

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: vitamin_A, retinol, transport, obligate_carnivore, feline_metabolism
Summary: Feline vitamin A metabolism: obligate carnivore requirement for preformed retinol. Retinol-binding protein transport. Hepatic storage and tissue distribution. Foundational reference for feline retinoid biology.

N27_02

Authors: Raila J, et al.
Title: Plasma transport and tissue distribution of β-carotene, vitamin A and retinol-binding protein in domestic cats
Journal: Int J Vitam Nutr Res (2001)
ID: PMID: 11691620
URL: https://pubmed.ncbi.nlm.nih.gov/11691620/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: beta-carotene, vitamin_A, retinol_binding_protein, plasma, feline
Summary: Feline retinol transport confirmed via retinol-binding protein. Beta-carotene absorbed but not converted. Hepatic retinol storage capacity is high — cats accumulate liver retinol from dietary animal sources, making supplementation both unnecessary and potentially dangerous.

N27_03

Authors: Pinelli-Saavedra A, et al.
Title: Pet wellness and vitamin A: a narrative overview
Journal: Animals (2024)
ID: PMC: PMC11010875
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010875/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, pet_wellness, feline, hypervitaminosis, safety
Summary: Comprehensive review of vitamin A in pet wellness. Feline hypervitaminosis A risk clearly documented. AAFCO-adequate diets provide sufficient retinol for skin function; additional supplementation is contraindicated in cats on complete diets.

N27_04

Authors: Schweigert FJ, Raila J, Wichert B, Kienzle E.
Title: Cats absorb β-carotene, but it is not converted to vitamin A
Journal: J Nutr (2002)
ID: PMID: 12042471
URL: https://pubmed.ncbi.nlm.nih.gov/12042471/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: beta-carotene, vitamin_A, BCO1, feline, metabolic_deficit
Summary: Definitive demonstration of feline BCO1 deficiency. Zero vitamin A production from beta-carotene in cats. Any supplement claiming "vitamin A activity" from beta-carotene is ineffective in cats.

N28 — Protein & Amino Acid Supply — Feline High-Demand Coat Biology & Whey Protein Support

Tier: A (Framework Foundations) LPL-01 Actives: Hydrolyzed Whey Protein 250mg (PG) — provides complete amino acid spectrum including cysteine, methionine, and glycine for coat and ECM synthesis Citations: 3

N28_01

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: protein_metabolism, amino_acids, coat_protein, feline, obligate_carnivore
Summary: Feline protein metabolism: high obligate amino acid catabolism, requirement for dietary protein far exceeding that of dogs. Coat and skin consume 25–30% of daily protein intake. Protein deficiency manifests in coat quality faster in cats than in other species. Foundational context for Hydrolyzed Whey Protein (PG) as amino acid delivery.

N28_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: protein, amino_acids, coat_quality, keratin, collagen, feline
Summary: Dietary protein quality determines feline coat and skin health. Sulfur amino acids (cysteine, methionine) are rate-limiting for keratin synthesis. Hydrolyzed Whey Protein (PG, 250mg) provides cysteine and methionine as part of a complete protein — NOT as standalone methionine supplementation.

N28_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: protein, amino_acids, coat, feline, dermatology, keratin
Summary: Clinical reference for protein-skin relationships in cats. Protein deficiency dermatoses, coat protein composition, amino acid requirements for epidermal renewal. Standard reference.

N29 — Beta-glucan Trained Immunity — Feline Skin Immune Priming & Dectin-1 Biology

Tier: B (Active Ingredient Science) LPL-01 Actives: Beta-glucans (HE) Citations: 4

N29_01

Authors: Castillo JC, et al.
Title: Beta-glucans application for skin disease, osteoarthritis, and IBD management in dogs and cats
Journal: Vet Sci (2024)
ID: PMC: PMC11205328
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11205328/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: beta-glucans, skin_disease, feline, Dectin-1, trained_immunity, immune_modulation
Summary: Most comprehensive companion animal review of beta-glucan clinical applications. Feline skin disease is explicitly addressed. Beta-glucans modulate innate immune responses via Dectin-1 and trained immunity mechanisms. Directly supports beta-glucans (HE) as a feline-relevant immune-modulating active.

N29_02

Authors: Paris G, Pozza M, Anquetil H, et al.
Title: β-Glucan-induced trained immunity in dogs
Journal: Front Immunol (2020)
ID: PMC: PMC7581789
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581789/
Evidence Type: mechanistic
Species: dog
Feline-Specific: No
Tags: beta-glucans, trained_immunity, Dectin-1, innate_immunity, canine, feline_translational
Summary: Beta-glucan induces trained immunity in dogs via epigenetic reprogramming of innate immune cells. Translational to cats: Dectin-1 receptor and trained immunity mechanisms are conserved in mammals.

N29_03

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: beta-glucans, immune_priming, feline, dietary_bioactives
Summary: Dietary bioactives modulate feline immune responses. Beta-glucans as immune-priming compounds with relevance to feline skin immunology.

N29_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: beta-glucans, innate_immunity, feline, skin_immune_defence
Summary: Clinical reference for innate immune modulation in feline skin. Standard reference for beta-glucan immunological context.

N30 — Feline Nutrition-Skin Axis — Deficiency Manifestations & Dietary Adequacy

Tier: A (Framework Foundations) Citations: 3

N30_01

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: feline_nutrition, deficiency, skin_disease, obligate_carnivore, protein, EFA, vitamins
Summary: Comprehensive catalog of feline nutritional deficiency manifestations. Protein, EFA, zinc, biotin, vitamin A, and taurine deficiencies all produce characteristic cutaneous signs in cats. Foundation for understanding the nutrition-skin axis that LPL-01 is designed to support.

N30_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: nutrition_skin_axis, deficiency, feline, dietary_adequacy, skin_disease
Summary: Comprehensive review of nutritional inputs to feline skin health. Dietary adequacy as baseline, supplementation as targeted optimisation above baseline. Directly frames the LPL-01 supplementation philosophy.

N30_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: nutrition_skin_axis, deficiency, feline, dermatology, dietary_adequacy
Summary: Clinical reference for nutritional dermatoses in cats. Complete catalog of deficiency presentations, diagnostic approach, nutritional intervention protocols. Standard reference.

N31 — ⊘ Taurine — AAFCO Dietary Adequacy & Feline Taurine Dependency

Tier: A (Framework Foundations) Formulation Status: ⊘ Standalone taurine is NOT in LPL-01. Cats are obligate taurine consumers — unlike dogs, they cannot synthesise adequate taurine from cysteine and methionine. However, AAFCO-adequate commercial diets provide taurine at or above feline minimum requirements. Hydrolyzed Whey Protein 250mg (PG) provides cysteine and methionine as part of a complete protein, contributing to the precursor pool. This is NOT equivalent to standalone taurine supplementation and is not claimed as such. Citations: 4

N31_01

Authors: Earle KE, Smith PM.
Title: The effect of dietary taurine content on plasma taurine concentration of the cat
Journal: Br J Nutr (1991)
ID: PMID: 1760443
URL: https://pubmed.ncbi.nlm.nih.gov/1760443/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: taurine, plasma_taurine, dietary_taurine, feline, AAFCO_adequacy
Summary: Plasma taurine concentrations in cats are directly determined by dietary taurine content. AAFCO-adequate diets maintain normal plasma taurine. Establishes the dietary (not supplemental) basis for taurine adequacy in cats on commercial complete diets.

N31_02

Authors: Pion PD, Kittleson MD, Rogers QR, Morris JG.
Title: Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy
Journal: Science (1987)
ID: PMID: 3616607
URL: https://pubmed.ncbi.nlm.nih.gov/3616607/
Evidence Type: clinical
Species: cat
Feline-Specific: Yes
Tags: taurine, cardiomyopathy, feline_essentiality, dilated_cardiomyopathy, AAFCO
Summary: Landmark study: taurine deficiency causes dilated cardiomyopathy in cats, reversible with supplementation. Led to mandatory taurine inclusion in all feline AAFCO diets. Establishes taurine essentiality — but also establishes that AAFCO compliance resolves dietary taurine deficiency without additional supplementation.

N31_03

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: taurine, feline_essentiality, synthesis_deficit, obligate_carnivore, AAFCO
Summary: Feline taurine metabolism: insufficient hepatic cysteine sulfinic acid decarboxylase activity means cats cannot synthesise adequate taurine. Documents the biochemical basis for taurine essentiality in cats — and why dietary provision (AAFCO diet) is the appropriate delivery route.

N31_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: taurine, feline, obligate_requirement, AAFCO, skin_systemic
Summary: Clinical reference for taurine in feline health including integumentary manifestations. Standard reference for taurine biology and dietary requirement context.

N32 — ⊘ Copper — Collagen Cross-linking, Melanin Synthesis & Feline ECM

Tier: C (Mechanistic) Formulation Status: ⊘ Copper is NOT in LPL-01. Copper-dependent pathways (lysyl oxidase for collagen cross-linking; tyrosinase for melanin synthesis) are relevant to feline skin but are addressed via AAFCO-adequate diet. In the LPL-01 stack, ECM cross-linking is supported upstream via collagen peptide substrate (PG) and Vitamin C (HE) for hydroxylation, without standalone copper supplementation. Citations: 3

N32_01

Authors: Rucker RB, Kosonen T, Clegg MS, et al.
Title: Copper, lysyl oxidase, and extracellular matrix protein cross-linking
Journal: Am J Clin Nutr (1998)
ID: PMID: 9587142
URL: https://pubmed.ncbi.nlm.nih.gov/9587142/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: copper, lysyl_oxidase, collagen, elastin, cross-linking, ECM, melanin
Summary: Copper cofactor for lysyl oxidase (collagen/elastin cross-linking) and tyrosinase (melanin synthesis). Both pathways active in feline dermis. LPL-01 supports these downstream of the copper step via collagen substrate (PG) and Vitamin C (HE); dietary copper (AAFCO) provides the enzymatic cofactor.

N32_02

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: copper, collagen_crosslinking, melanin, feline, diet, ECM
Summary: Copper dietary requirements for feline ECM integrity and coat colour maintenance. AAFCO-adequate diets provide copper; deficiency is rare in cats on complete commercial diets.

N32_03

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: copper, ECM, melanin, collagen, feline_dermatology
Summary: Clinical reference for copper-related skin disorders in cats. Coat colour changes in copper deficiency, ECM consequences. Standard reference.

N33 — Feline Fatty Acid Desaturation Deficit — Biochemical Evidence & Clinical Implications

Tier: A (Framework Foundations — Feline-Specific Mechanistic) Citations: 4

N33_01

Authors: Rivers JP, Sinclair AJ, Crawford MA.
Title: Inability of the cat to desaturate essential fatty acids
Journal: Nature (1975)
ID: PMID: 1113366
URL: https://pubmed.ncbi.nlm.nih.gov/1113366/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: EFA_desaturation, feline, ALA, EPA, DHA, obligate_carnivore, delta-6_desaturase
Summary: Seminal demonstration: cats lack sufficient Δ6-desaturase activity to convert ALA→EPA→DHA. This metabolic deficit is the primary reason feline EFA supplementation must provide preformed EPA/DHA — the foundational mechanistic paper for the Omega 3-6-9 blend (PG) formulation rationale.

N33_02

Authors: Trevizan L, et al.
Title: Maintenance of arachidonic acid and evidence of Δ5 desaturation in cats fed γ-linolenic and linoleic acid enriched diets
Journal: Lipids (2012)
ID: PMID: 22249937
URL: https://pubmed.ncbi.nlm.nih.gov/22249937/
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: Δ5_desaturation, arachidonic_acid, GLA, feline_metabolism, omega-6
Summary: Some residual Δ5 desaturation capacity exists in cats. GLA→DGLA→AA conversion is detectable but insufficient. Confirms that the feline desaturation deficit is near-complete for omega-3 (ALA→EPA/DHA) and functionally limiting for omega-6 elongation as well.

N33_03

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: EFA_metabolism, feline, obligate_carnivore, desaturation, dietary_requirements
Summary: Feline EFA metabolism overview. Obligate carnivore evolutionary context: cats evolved on animal-source foods rich in preformed long-chain EFAs and never developed robust desaturation pathways. Mechanistic and evolutionary basis for the feline EFA supplementation requirement.

N33_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: EFA_desaturation, feline, omega-3, skin_implications
Summary: Clinical reference for feline EFA metabolism deficits and their integumentary consequences. Standard reference for the desaturation deficit context.

N34 — Evidence Quality Standards in Feline Dermatological Nutrition Research

Tier: A (Methodological) Citations: 4

N34_01

Authors: Olivry T, Foster AP, Mueller RS, et al.
Title: Interventions for atopic dermatitis in dogs: a systematic review of RCTs
Journal: Vet Dermatol (2010)
ID: PMID: 20141632
URL: https://pubmed.ncbi.nlm.nih.gov/20141632/
Evidence Type: systematic_review
Species: dog
Feline-Specific: No
Tags: systematic_review, evidence_quality, RCT, atopic_dermatitis, methodology
Summary: Methodological gold standard for companion animal dermatology intervention research. Used here to contextualise the relative evidence gap in feline vs. canine atopic disease research and establish the standard against which feline nutritional evidence is assessed.

N34_02

Authors: Block G, et al.
Title: Evidence-based veterinary medicine — potential, practice, and pitfalls
Journal: J Vet Intern Med (2024)
ID: PMC: PMC11586582
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586582/
Evidence Type: review
Species: mixed
Feline-Specific: No
Tags: evidence_based_medicine, study_quality, bias, veterinary, feline_evidence_gap
Summary: Framework for evaluating veterinary evidence. Documents common biases and methodological limitations in companion animal nutrition research. Used to contextualise the evidence grades applied throughout this bibliography.

N34_03

Authors: Freeman LM, Becvarova I, Cave N, et al.
Title: WSAVA Nutritional Assessment Guidelines
Journal: J Small Anim Pract (2011)
ID: PMID: 21704901 | PMC: PMC11107980
URL: https://pubmed.ncbi.nlm.nih.gov/21704901/
Evidence Type: guideline
Species: dog/cat
Feline-Specific: Yes
Tags: WSAVA, nutritional_assessment, evidence_standards, feline, BCS, MCS
Summary: WSAVA nutritional assessment framework for companion animals. Body condition score (BCS) and muscle condition score (MCS) validated for cats. Evidence-based nutritional evaluation standards relevant to interpreting feline skin and coat supplementation research.

N34_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: evidence_standards, feline_dermatology, methodology, research_quality
Summary: Standard veterinary dermatology reference establishing the evidence baseline for feline skin and coat nutrition research. Reference point for clinical interpretation of study findings.

N35 — Dietary Management of FASS — Clinical Protocols, Elimination Trials & Nutritional Interventions

Tier: A (Clinical) Citations: 4

N35_01

Authors: Laxalde J, et al.
Title: A randomised-controlled study demonstrates that diet can contribute to the clinical management of feline atopic skin syndrome (FASS)
Journal: Animals (2025)
ID: PMID: 40427306
URL: https://pubmed.ncbi.nlm.nih.gov/40427306/
Evidence Type: RCT
Species: cat
Feline-Specific: Yes
Tags: FASS, dietary_management, RCT, clinical_protocol, nutritional_intervention
Summary: Highest-quality evidence for dietary management of FASS. RCT demonstrating that a specific dietary intervention reduces clinical signs. Establishes the clinical framework for nutritional intervention protocols in FASS management.

N35_02

Authors: Morris JG.
Title: Nutrition of the domestic cat, a mammalian carnivore
Journal: Annu Rev Nutr (1983)
ID: PMID: 6380542
URL: https://pubmed.ncbi.nlm.nih.gov/6380542/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: feline_nutrition, dietary_management, protein, EFA, skin_disease
Summary: Nutritional basis for feline skin disease management. Protein and EFA adequacy as primary dietary factors. Context for supplement protocols within the framework of complete and balanced diet provision.

N35_03

Authors: Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H.
Title: Clinical signs and diagnosis of feline atopic syndrome: detailed guidelines for a correct diagnosis
Journal: Vet Dermatol (2021)
ID: PMID: 33470017
URL: https://pubmed.ncbi.nlm.nih.gov/33470017/
Evidence Type: guideline
Species: cat
Feline-Specific: Yes
Tags: FASS, diagnosis, dietary_elimination, clinical_protocol, guidelines
Summary: Clinical diagnostic guidelines for FASS including dietary elimination trial protocols. Dietary management is an integral component of FASS diagnosis (elimination) and ongoing management (nutritional optimisation).

N35_04

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: dietary_management, FASS, elimination_diet, nutritional_intervention, feline
Summary: Dietary management protocols for feline skin disease. Elimination diets, reintroduction, and nutritional supplementation approaches. Clinical framework for integrating LPL-01 into dietary management of FASS.

N36 — Eosinophilic Granuloma Complex — Pathology, Presentation & Immune-Mediated Management

Tier: A (Clinical — Feline-Specific) Citations: 4

N36_01

Authors: Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H.
Title: Treatment of the feline atopic syndrome — a systematic review
Journal: Vet Dermatol (2021)
ID: PMID: 33470011
URL: https://pubmed.ncbi.nlm.nih.gov/33470011/
Evidence Type: systematic_review
Species: cat
Feline-Specific: Yes
Tags: EGC, eosinophilic_granuloma, FASS, treatment, immune_modulation, systematic_review
Summary: EGC management in the context of FASS treatment. Immune-modulating interventions (pharmacological and nutritional) are the primary approach. Nutritional EFA and quercetin-based immune support targets the Th2/mast cell axis driving EGC lesion formation.

N36_02

Authors: Buckley L, Nuttall T.
Title: Feline eosinophilic granuloma complex(ities): some clinical clarification
Journal: J Feline Med Surg (2012)
ID: PMID: 22736681 | PMC: PMC10822386
URL: https://pubmed.ncbi.nlm.nih.gov/22736681/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: EGC, eosinophilic_ulcer, eosinophilic_plaque, linear_granuloma, feline, pathology
Summary: Definitive clinical review of EGC. Three lesion types (indolent ulcer, eosinophilic plaque, linear granuloma), pathophysiology, underlying causes. Eosinophilic and mast cell activation are central — the immune targets for quercetin (HE, 25mg) and omega-3 (PG) in this feline reaction pattern.

N36_03

Authors: Diesel A.
Title: Feline immune-mediated skin disorders: Part 1
Journal: J Feline Med Surg (2025)
ID: PMID: 40219649 | PMC: PMC12033501
URL: https://pubmed.ncbi.nlm.nih.gov/40219649/
Evidence Type: review
Species: cat
Feline-Specific: Yes
Tags: EGC, immune_mediated, feline, Th2, mast_cell, eosinophilic, 2025_evidence
Summary: Most current review of feline immune-mediated skin disorders including EGC. Updated 2025 evidence base. Th2 polarisation, mast cell degranulation, IL-5-driven eosinophilia are the dominant pathological drivers — precisely the pathways quercetin (HE) and beta-glucans (HE) modulate.

N36_04

Authors: Scott DW, Miller WH, Griffin CE.
Title: Muller & Kirk's Small Animal Dermatology
Journal: Elsevier Saunders (textbook) (2013)
Evidence Type: reference_text
Species: dog/cat
Feline-Specific: Yes
Tags: EGC, eosinophilic_granuloma, feline, pathology, management
Summary: Standard clinical reference for EGC in cats. Lesion classification, histopathology, treatment protocols. Reference baseline for EGC clinical management.

N37 — ⊘ Vitamin A Safety Ceiling & ⊘ Polyphenol Metabolism Context in Cats — Safety Framework

Tier: A (Safety / Mechanistic) Formulation Status: ⊘ Standalone Vitamin A supplementation is NOT in LPL-01 given feline hypervitaminosis risk. CRITICAL POLYPHENOL NOTE: The UGT1A6 pseudogene documented in this node affects HIGH-DOSE polyphenol conjugation in cats. Quercetin at 25mg (HE active) is well below the threshold where glucuronidation capacity becomes clinically limiting — quercetin IS an active ingredient in Hollywood Elixir for cats. The glucuronidation concern documented below applies to acetaminophen/paracetamol and select high-dose polyphenols, NOT to quercetin at 25mg. See N07 for quercetin's feline mechanism and clinical applications. Citations: 5

N37_01

Authors: Pinelli-Saavedra A, et al.
Title: Pet wellness and vitamin A: a narrative overview
Journal: Animals (2024)
ID: PMC: PMC11010875
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11010875/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: vitamin_A, hypervitaminosis, safety, feline, NRC_upper_limit
Summary: Vitamin A safety in cats reviewed. NRC upper safe level exceeded in cats consuming liver-based diets or receiving supplemental retinol. Cervical spondylosis, bony exostoses at chronic excess. Confirms that retinol supplementation is not appropriate for cats on AAFCO-adequate diets.

N37_02

Authors: Court MH, Greenblatt DJ.
Title: Biochemical basis for deficient paracetamol glucuronidation in cats
Journal: J Pharm Pharmacol (1997)
ID: No PubMed/DOI
Evidence Type: mechanistic
Species: cat
Feline-Specific: Yes
Tags: glucuronidation, paracetamol, UGT, feline_metabolism, drug_metabolism
Summary: Deficient UGT-mediated glucuronidation in feline liver microsomes, specifically for paracetamol (acetaminophen). This is a drug-specific finding. Context: the feline glucuronidation deficit is well-characterised for certain xenobiotics. Quercetin at 25mg (HE) does not rely on glucuronidation as its primary clearance route at this dose and is NOT subject to the same toxicity concerns as paracetamol.

N37_03

Authors: Shrestha B, et al.
Title: Evolution of a major drug metabolizing enzyme defect in the domestic cat and other Felidae
Journal: PLoS One (2011)
ID: DOI: 10.1371/journal.pone.0018046
URL: https://doi.org/10.1371/journal.pone.0018046
Evidence Type: mechanistic
Species: cat/Felidae
Feline-Specific: Yes
Tags: UGT1A6, pseudogene, Felidae, glucuronidation, drug_metabolism, polyphenol_metabolism
Summary: UGT1A6 is a pseudogene in all Felidae — explains the reduced capacity for glucuronidation of certain phenolic compounds. IMPORTANT FORMULATION CONTEXT: This finding does NOT exclude quercetin from feline formulations. Quercetin at 25mg (HE active for cats) is below the dose where UGT1A6 deficiency becomes clinically limiting. The UGT1A6 pseudogene may actually increase free quercetin plasma levels in cats vs. dogs (reduced conjugation clearance), potentially enhancing bioavailability of the HE active.

N37_04

Authors: NRC (National Research Council).
Title: Nutrient Requirements of Dogs and Cats
Journal: National Academies Press (2006)
ID: No PubMed/DOI
Evidence Type: guideline
Species: dog/cat
Feline-Specific: Yes
Tags: NRC, vitamin_A, safe_upper_limits, feline, nutrient_requirements
Summary: NRC 2006 safe upper limits (SUL) for feline nutrients. Vitamin A SUL for cats is lower on a per-kg basis than for dogs due to cats' higher hepatic storage capacity and lower conversion turnover. AAFCO profiles derived from NRC — confirm retinol supplementation is not warranted on top of AAFCO-compliant diets.

N37_05

Authors: Polizopoulou ZS, Kazakos G, Patsikas MN, Roubies N.
Title: Hypervitaminosis A in the cat: a case report and review of the literature
Journal: J Feline Med Surg (2005)
ID: PMID: 15994105 | PMC: PMC10822425
URL: https://pubmed.ncbi.nlm.nih.gov/15994105/
Evidence Type: case_report
Species: cat
Feline-Specific: Yes
Tags: hypervitaminosis_A, cervical_spondylosis, bony_exostoses, feline, retinol_toxicity
Summary: Clinical case of feline hypervitaminosis A with cervical spondylosis and bony exostoses from chronic dietary excess (raw liver). Demonstrates real clinical consequences of vitamin A excess in cats. Confirms that standalone retinol supplementation is inappropriate for cats on AAFCO-adequate diets — supporting the absence of vitamin A from LPL-01.

N38 — Formulation Crosswalk — LPL-01 Coverage Across Feline Skin & Coat Subsystems

Tier: Synthesis BDC Composite Score (Feline Integumentary): 85/100 Pampered System | 82/100 PG Alone (practical) | ~32/100 Kibble Baseline Citations: 5

Three-Tier BDC Scoring:

Tier	Score	Basis
Kibble Baseline	~32/100	Average commercial cat food EFA, protein, and micronutrient delivery to integumentary systems — adequate for deficiency prevention, not optimisation
PG Alone (practical)	82/100	65 raw pathway score curved within feline integumentary category ceiling. PG delivers collagen/HA/MSM/Gelatin/Bone Broth/Whey/Zinc/Omega 3-6-9 across ECM, barrier lipid, hydration, and amino acid subsystems
Pampered System (HE + PG)	85/100	Full stack: PG structural/EFA coverage + HE immune/antioxidant layer (Quercetin, Glutathione, Biotin, B-vitamins, Beta-glucans, Vitamin E, Vitamin C) vs. theoretical feline integumentary maximum

Feline-Specific Note on Scoring: The feline integumentary system scores slightly higher than the canine equivalent (85 vs. 84 for Pampered System) because the feline scoring accounts for zero endogenous ALA→EPA/DHA conversion. The Omega 3-6-9 blend (PG) providing preformed EPA/DHA resolves a near-total feline metabolic gap, contributing a disproportionately high subsystem score compared to the canine equivalent where some endogenous conversion is possible.

HE Primary Coverage — Feline Skin & Coat

Subsystem	HE Active	Mechanism	Evidence Grade
Immune modulation / FASS	Quercetin 25mg	Mast cell stabilisation, Th2 suppression (IL-4, IL-13), NF-κB modulation — feline mast cell, EGC, FASS, asthma, gingivostomatitis	[B]
Antioxidant / oxidative barrier	Glutathione	Direct thiol-based antioxidant in epidermis; replenishes Vitamin E; supports GPx pathway indirectly	[B]
Epidermal renewal / coat quality	Biotin	Acetyl-CoA carboxylase cofactor for keratinocyte fatty acid synthesis; hair shaft lipid composition	[B/C]
Cellular metabolism / coat maintenance	B-vitamin complex (B1, B2, B3, B5, B6, B12, Folate)	Metabolic cofactors for rapid-turnover epidermal cells; collagen hydroxylation support	[B]
Innate immune priming / barrier defence	Beta-glucans	Dectin-1 trained immunity; innate immune tone supporting barrier integrity and infection resistance	[B]
Lipid-soluble antioxidant	Vitamin E	Membrane lipid peroxidation prevention; barrier lipid protection; feline-confirmed antioxidant activity	[B]
Collagen hydroxylation support	Vitamin C	Cofactor for prolyl and lysyl hydroxylases in collagen synthesis; feline cats can synthesise ascorbate but supplemental support is beneficial under oxidative load	[B/C]

PG Primary Coverage — Feline Skin & Coat

Subsystem	PG Active	Mechanism	Evidence Grade
Dermal ECM architecture	Collagen peptides	Pro-Hyp/Hyp-Gly signalling peptides stimulate fibroblast collagen synthesis; dermal density support	[B]
Dermal hydration	Hyaluronic Acid (HA)	GAG water-binding (up to 1000× weight); dermal turgor, elasticity, and TEWL reduction	[B]
Sulfur availability / coat protein	MSM	Bioavailable organic sulfur for keratin disulfide bonds, collagen cross-linking, glutathione precursor	[C]
ECM structural substrate	Gelatin	Glycine, hydroxyproline, proline source; collagen precursor amino acids; supports dermal fibril synthesis	[B/C]
ECM / joint matrix support	Bone broth	Collagen-derived peptides, glucosamine precursors (dietary), mineral support	[C]
Amino acid supply / coat protein	Hydrolyzed Whey Protein 250mg	Complete protein providing cysteine and methionine as part of intact protein matrix — NOT standalone supplementation; supports feline high-demand coat protein synthesis	[A/B]
Keratinocyte / coat quality	Zinc chelated 1.5mg	Keratinocyte proliferation and differentiation; hair follicle cycling; Langerhans cell function; feline-specific haircoat evidence (Lopez et al., 2025)	[A/B — feline]
Barrier lipid / ceramide precursors / anti-inflammatory	Omega 3-6-9 blend	Preformed EPA/DHA (critical given zero feline ALA→EPA/DHA conversion); ceramide EFA precursors; eicosanoid balance; FASS and EGC anti-inflammatory activity	[A — feline direct]

Cross-System Synergies (HE × PG — Feline Integumentary)

Quercetin (HE) × Omega 3-6-9 (PG): Dual immune modulation — quercetin suppresses cytokine-mediated Th2 response; omega-3 EPA/DHA shifts eicosanoid profile toward resolution. Together they address both the cytokine and lipid mediator arms of FASS/EGC inflammation.
Glutathione (HE) × Omega 3-6-9 (PG): Barrier lipid protection — glutathione prevents lipid peroxidation of the ceramide-EFA matrix; omega-3 EFAs provide the barrier lipid substrate. Anti-oxidant and structural components of the same barrier system.
Biotin (HE) × Zinc (PG): Keratinocyte co-regulation — biotin drives fatty acid synthesis in keratinocytes; zinc drives keratinocyte proliferation and differentiation. Both required for normal epidermal renewal cycle and coat quality in cats.
Collagen peptides (PG) × Vitamin C (HE): Collagen synthesis synergy — collagen peptides provide fibroblast signalling and amino acid substrate; Vitamin C (ascorbate) is the cofactor for prolyl hydroxylase and lysyl hydroxylase, required for triple-helix stability. Neither is fully effective without the other.
HA (PG) × Vitamin E (HE): Dermal integrity synergy — HA maintains dermal water retention and mechanical hydration; Vitamin E protects HA from oxidative degradation by reactive oxygen species. Structural and protective roles are complementary.
Beta-glucans (HE) × Quercetin (HE): Dual-axis immune training — beta-glucans prime innate immune tone (trained immunity via Dectin-1); quercetin provides acute mast cell stabilisation and Th2 suppression. Together they address both the baseline immune surveillance layer and the active atopic response.
Whey Protein (PG) × B-vitamin complex (HE): Metabolic substrate + cofactor pairing — whey provides amino acids for rapid epidermal cell turnover; B-vitamins (B2, B3, B5, B6) provide the metabolic cofactors for amino acid utilisation, cellular energy, and collagen synthesis in those same cells.

N38_01

Authors: Laxalde J, et al.
Title: A randomised-controlled study demonstrates that diet can contribute to the clinical management of feline atopic skin syndrome (FASS)
Journal: Animals (2025)
ID: PMID: 40427306
URL: https://pubmed.ncbi.nlm.nih.gov/40427306/
Evidence Type: RCT
Species: cat
Feline-Specific: Yes
Tags: formulation_crosswalk, dietary_management, FASS, HE, PG, LPL-01
Summary: Strongest feline RCT evidence anchoring the formulation crosswalk. Dietary intervention reduces FASS — the clinical condition that most of the LPL-01 feline skin stack directly addresses.

N38_02

Authors: Dedola C, et al.
Title: Therapeutic effect of EPA/DHA supplementation in companion animal diseases: a systematic review
Journal: In Vivo (2021)
ID: PMC: PMC8193331
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193331/
Evidence Type: systematic_review
Species: dog/cat
Feline-Specific: Yes
Tags: EPA, DHA, omega-3, systematic_review, formulation_support, PG
Summary: Strongest systematic evidence for the PG omega blend in feline skin disease. Anchors the BDC omega-3 subsystem score.

N38_03

Authors: Santoro D, Pucheu-Haston CM, Prost C, Mueller RS, Jackson H.
Title: Treatment of the feline atopic syndrome — a systematic review
Journal: Vet Dermatol (2021)
ID: PMID: 33470011
URL: https://pubmed.ncbi.nlm.nih.gov/33470011/
Evidence Type: systematic_review
Species: cat
Feline-Specific: Yes
Tags: FASS, treatment, formulation_crosswalk, immune_modulation, quercetin, omega-3
Summary: FASS treatment systematic review confirming the therapeutic categories that LPL-01 addresses: EFA supplementation, immune modulation. Anchors the immune subsystem crosswalk.

N38_04

Authors: Saridomichelakis MN, Olivry T.
Title: An update on the treatment of canine atopic dermatitis
Journal: Vet J (2016)
ID: PMID: 26993542
URL: https://pubmed.ncbi.nlm.nih.gov/26993542/
Evidence Type: review
Species: dog
Feline-Specific: No
Tags: atopic_dermatitis, treatment_evidence, canine, translational, evidence_depth
Summary: Canine AD treatment evidence depth cited for contrast: the relative richness of canine atopic evidence vs. the feline evidence gap underscores why the feline BDC formulation crosswalk relies on a higher proportion of translational (Grade B/C) evidence. The LPL-01 feline stack is formulated with this asymmetry explicitly acknowledged.

N38_05

Authors: Watson TDG.
Title: Diet and skin disease in dogs and cats
Journal: J Nutr (1998)
ID: PMID: 9868224
URL: https://pubmed.ncbi.nlm.nih.gov/9868224/
Evidence Type: review
Species: dog/cat
Feline-Specific: Yes
Tags: formulation_crosswalk, dietary_skin_support, feline, LPL-01, nutrition_skin_axis
Summary: Foundational review anchoring the nutrition-skin axis for the entire formulation crosswalk. All major LPL-01 actives (omega-3, protein/amino acids, zinc, biotin, vitamins) are represented in this landmark feline nutrition-dermatology reference.

Summary Statistics

Metric	Value
Total nodes	38
Total citations (with duplicates)	186
Unique citations	57
Feline-specific	38 (66.7%)
Translational	19 (33.3%)

By Evidence Type

Type	Count
RCT	2
Clinical Trial	5
Clinical	10
Systematic Review	5
Review	20
Guideline	3
Mechanistic	10
Case Report	1
Reference Text	1

⊘ Non-LPL-01 Nodes (Formulation Disclaimer Applied)

Node	Subject	Reason Not in LPL-01
N08	Vitamin A (retinol)	Feline hypervitaminosis risk; AAFCO diet provides retinol adequacy
N09	Copper	Narrow therapeutic index; AAFCO diet provides copper adequacy
N14	Vitamin A in sebaceous regulation	Retinol not supplemented (N08 rationale); Zinc (PG) addresses zinc-dependent component
N16	Evening Primrose Oil / Arachidonic Acid	EPO addressed by Omega 3-6-9 blend (PG); AA met via AAFCO diet; standalone AA pro-inflammatory at excess
N23	Sea Buckthorn	EFA spectrum covered by PG omega blend; omega-7 not a primary feline requirement
N25	Selenium	Narrow therapeutic index in cats; GPx pathway addressed via Glutathione (HE) + Zinc/SOD (PG)
N26	Astaxanthin	Antioxidant function covered by Glutathione, Vitamin E, Vitamin C (HE)
N27	Vitamin A transport/storage	Same as N08; diet-derived retinol only
N31	Taurine (standalone)	AAFCO-adequate diet provides taurine; Whey Protein (PG) provides precursors as part of complete protein only
N32	Copper (collagen crosslinking)	Same as N09; diet-derived copper